{"gene":"RRAD","run_date":"2026-06-10T07:46:27","timeline":{"discoveries":[{"year":1993,"finding":"RRAD (Rad) was identified as a new ~29 kDa member of the Ras-GTPase superfamily, overexpressed in skeletal muscle of type II diabetic humans, establishing it as a novel small GTPase expressed primarily in skeletal and cardiac muscle.","method":"Subtraction cloning of human skeletal muscle cDNA libraries, followed by molecular characterization of the encoded protein","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 / Strong — original identification paper using direct molecular cloning and characterization, foundational discovery replicated in subsequent work","pmids":["8248782"],"is_preprint":false},{"year":1995,"finding":"Rad binds GTP in a specific and saturable manner, has low intrinsic GTPase activity that is enhanced by a tissue-specific GAP activity distinct from known Ras-GAPs, and is phosphorylated in vitro by PKA at two C-terminal sites. GDP binding is lost with the S66N mutation (equivalent to Ras position 12).","method":"Bacterial GST-fusion protein expression, GTP/GDP binding assays, GTPase activity assays, site-directed mutagenesis, in vitro phosphorylation with PKA, phosphopeptide mapping","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple in vitro biochemical assays with mutagenesis in a single rigorous study","pmids":["7876254"],"is_preprint":false},{"year":1996,"finding":"Rad interacts with skeletal muscle beta-tropomyosin; this interaction is guanine nucleotide-dependent (GDP-Rad binds tropomyosin better than GTP-Rad) and is enhanced by calcium ionophore A23187. Calcium promotes Rad association with the cytoskeletal fraction in C2C12 cells.","method":"Expression screening of cDNA libraries, co-immunoprecipitation in C2C12 cells, calcium ionophore treatment, far-Western blotting, guanine nucleotide saturation studies, subcellular fractionation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods (library screen, co-IP, far-Western, fractionation) establishing binding partner and nucleotide-state dependence","pmids":["8557685"],"is_preprint":false},{"year":1996,"finding":"Overexpression of Rad in C2C12 myotubes, L6 myotubes, and 3T3-L1 adipocytes reduces insulin-stimulated glucose uptake by 50–90% without altering GLUT4 expression, GLUT4 translocation, or insulin receptor/IRS-1 phosphorylation or PI3-kinase activity, suggesting Rad inhibits intrinsic transporter activity.","method":"Stable and transient overexpression in muscle and fat cell lines, 2-deoxyglucose and 3-O-methylglucose uptake assays, GLUT4 immunofluorescence, Western blot for signaling intermediates, PI3-kinase assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean overexpression with multiple orthogonal functional readouts across three cell lines","pmids":["8798502"],"is_preprint":false},{"year":1997,"finding":"Rad and Gem bind calmodulin (CaM) in a calcium-dependent manner; the binding site maps to residues 278–297 at the Rad C-terminus, which contains a canonical CaM-binding motif. GDP-bound Rad shows ~5-fold better CaM binding than GTP-bound Rad. Rad co-immunoprecipitates with CaMKII in C2C12 cells, and both Rad and Gem serve as CaMKII substrates in vitro. An extended N-terminal domain negatively regulates CaM binding.","method":"CaM-Sepharose pulldown, co-immunoprecipitation, deletion and point mutant analysis, in vitro CaMKII kinase assay, subcellular fractionation correlating CaM binding with cytoskeletal localization","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — reconstitution (CaM pulldown), mutagenesis mapping, co-IP, and in vitro kinase assay in single study with multiple orthogonal methods","pmids":["9115241"],"is_preprint":false},{"year":1998,"finding":"Rad is phosphorylated by CaMKII and PKA at Ser273, and by PKC and CKII at multiple C-terminal serines (Ser214, Ser257, Ser273, Ser290, Ser299). Phosphorylation by PKC and CKII abolishes Rad–calmodulin interaction. PKA incubation decreases GTP binding (~60–70%) independently of Ser273 phosphorylation.","method":"In vitro kinase assays with PKA, CaMKII, PKC, CKII; deletion and point mutagenesis; phosphopeptide mapping; GTP binding assays; CaM-Sepharose pulldown","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — systematic mutagenesis combined with multiple in vitro kinase assays and functional readouts in single rigorous study","pmids":["9677319"],"is_preprint":false},{"year":1998,"finding":"Rad associates with the cytoskeleton and plasma/internal membranes in C2C12 cells through a non-lipid-dependent mechanism; it is not palmitoylated, isoprenylation inhibition does not alter its distribution, and removal of the C-terminal 11 amino acids does not affect localization. Addition of the H-Ras C-terminal 9 amino acids to truncated Rad redistributes it to the membrane skeleton independently of lipid modification.","method":"Biosynthetic [3H]palmitate labeling, lovastatin treatment, Triton X-114 phase partitioning, subcellular fractionation, C-terminal deletion and chimeric construct expression in C2C12 cells","journal":"Experimental cell research","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods defining non-lipid membrane/cytoskeletal association mechanism","pmids":["9683526"],"is_preprint":false},{"year":1999,"finding":"The GTPase-activating protein (GAP) for Rad is nm23 (NDP kinase/metastasis suppressor): nm23 antibodies deplete Rad-GAP activity from skeletal muscle cytosol, recombinant nm23 reconstitutes this activity, and GAP activity is absent with the S105N dominant-negative Rad mutant. Simultaneously, Rad (but not S105N-Rad) enhances nm23 NDP kinase activity and decreases nm23 autophosphorylation, constituting a bidirectional regulatory interaction.","method":"Rad-GAP purification, immunodepletion with nm23 antibodies, reconstitution with recombinant nm23, GTPase assays, NDP kinase assays, autophosphorylation assays, transfection of melanoma cells","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution with purified proteins plus immunodepletion, multiple orthogonal biochemical assays establishing bidirectional regulation","pmids":["10611312"],"is_preprint":false},{"year":2002,"finding":"Rad (and Gem) interact with Rho kinase (ROK) alpha and beta, functioning as negative regulators of the Rho–ROK pathway. Gem binds ROKbeta independently of RhoA in the ROKbeta coiled-coil region adjacent to the Rho binding domain, inhibiting ROKbeta-mediated phosphorylation of myosin light chain and myosin phosphatase but not LIM kinase. Rad opposes ROKalpha-mediated cell rounding. Expression of Rad or Gem in epithelial/fibroblast cells causes stress fiber and focal adhesion disassembly.","method":"Co-immunoprecipitation, ROK kinase assays, interference assays with ROK deletion mutants, overexpression in N1E-115 and epithelial/fibroblast cells with morphological readouts","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, kinase assays, deletion mutant binding domain mapping, multiple cell line functional assays","pmids":["11956230"],"is_preprint":false},{"year":2003,"finding":"Rad (and Rem) bind directly to L-type Ca2+ channel beta-subunits (CaVβ) in vivo, and co-expression of Rad or Rem with CaV1.2/CaVβ2a in HEK293 cells abolishes L-type Ca2+ channel currents. T-type (CaV3) channels that lack accessory subunits are not inhibited by Rem, indicating RGK inhibition is beta-subunit-dependent. The Rem C-terminus is critical for both CaVβ binding and channel regulation.","method":"Co-immunoprecipitation in vivo, whole-cell patch-clamp electrophysiology in HEK293 cells, C-terminal deletion analysis, overexpression in C2C12 myoblasts","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — co-IP establishing direct binding, electrophysiology confirming functional consequence, deletion analysis, multiple cell contexts","pmids":["14623965"],"is_preprint":false},{"year":2005,"finding":"14-3-3 and calmodulin binding regulate the subcellular distribution of Rad; both Rad and Rem inhibit Ca2+ channel activity by preventing surface expression of functional Ca2+ channels. Nuclear targeting of Rad or Rem can sequester the CaVβ-subunit to the nucleus, providing a novel mechanism for Ca2+ channel downregulation. This regulation by calmodulin and 14-3-3 is Rad-specific and not observed for Rem.","method":"Subcellular fractionation, confocal immunofluorescence, co-immunoprecipitation, electrophysiology, nuclear targeting constructs in transfected cells","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (fractionation, imaging, co-IP, electrophysiology) defining novel beta-subunit nuclear sequestration mechanism","pmids":["16298391"],"is_preprint":false},{"year":2005,"finding":"Rad is a p53-regulated gene whose promoter contains a p53-binding site; p53 activation by DNA damage induces Rad expression. Rad overexpression in vascular smooth muscle cells (VSMCs) inhibits VSMC attachment and migration and reduces focal contacts and stress fibers by blocking Rho/ROK signaling. Adenoviral Rad delivery reduces neointimal formation in balloon-injured rat carotid arteries; a GDP-binding but not GTP-binding mutant of Rad increases neointimal formation.","method":"Adenoviral gene delivery in rat carotid injury model, immunohistochemistry, real-time RT-PCR, VSMC migration and adhesion assays, morphometric analysis, overexpression with signaling readouts","journal":"Circulation","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo model with multiple genetic tools (WT Rad, dominant-negative mutant) and functional readouts including migration, signaling, and vascular remodeling","pmids":["15710763"],"is_preprint":false},{"year":2005,"finding":"Rad is expressed in myogenic progenitor cells during skeletal muscle regeneration. Myogenic transcription factors MEF2, MyoD, and Myf-5 increase Rad promoter transcriptional activity, and this is enhanced by calcineurin (calcium-dependent phosphatase); the effect depends on a conserved NFAT binding motif in the Rad promoter.","method":"Microarray analysis, immunohistochemistry, promoter-reporter assays, calcineurin co-transfection, NFAT motif mutagenesis in regenerating mouse skeletal muscle","journal":"American journal of physiology. Cell physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter functional assays with mutagenesis and transcription factor co-expression, single lab study","pmids":["16221735"],"is_preprint":false},{"year":2006,"finding":"Overexpression of Rad in skeletal muscle in transgenic mice worsens high-fat-diet-induced insulin resistance and glucose intolerance, establishing an in vivo role for Rad as a negative regulator of muscle glucose metabolism. Rad transgenic mice also show reduced plasma triglyceride levels associated with increased lipoprotein lipase.","method":"Transgenic mice with muscle-specific (MCK promoter) Rad overexpression, glucose tolerance tests, insulin clamp, 2-deoxyglucose uptake assays, lipoprotein lipase measurements","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo transgenic model with quantitative metabolic phenotyping across multiple readouts","pmids":["16537411"],"is_preprint":false},{"year":2007,"finding":"Rad mRNA and protein are significantly decreased in human failing hearts and in pressure-overload or phenylephrine-induced cardiac hypertrophy. Gain-of-function and loss-of-function of Rad in cardiomyocytes respectively inhibits and increases phenylephrine-induced hypertrophy. Rad overexpression inhibits CaMKII activation. Rad-deficient mice show increased susceptibility to cardiac hypertrophy with elevated CaMKII phosphorylation, placing Rad upstream of CaMKII in the anti-hypertrophic pathway.","method":"Western blot of human and mouse heart tissue, adenoviral overexpression and RNAi knockdown in cardiomyocytes, Rad-knockout mice, pressure-overload model, CaMKII phosphorylation assays","journal":"Circulation","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic (KO mice, KD, overexpression) and biochemical (CaMKII phosphorylation) in multiple model systems including human tissue","pmids":["18056528"],"is_preprint":false},{"year":2009,"finding":"Rad is a novel endogenous regulator of cardiac excitation-contraction (EC) coupling: adenoviral overexpression of Rad (~3-fold) in rat cardiomyocytes suppresses L-type Ca2+ channel current (ICaL), Ca2+ transients, and contractility, while ~70% Rad knockdown by RNAi increases ICaL, Ca2+ transients, and contractility. The dominant-negative mutant RadS105N mimics knockdown effects on ICaL. Rad overexpression negates beta-adrenergic receptor effects on ICaL and Ca2+ transients.","method":"Adenoviral overexpression and RNAi knockdown in rat cardiomyocytes, patch-clamp electrophysiology, Ca2+ imaging, sarcomere shortening measurement, dominant-negative mutant RadS105N","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — rigorous electrophysiology combined with gain- and loss-of-function, dominant-negative mutant, multiple functional readouts in single study","pmids":["19926875"],"is_preprint":false},{"year":2011,"finding":"Rad is a direct transcriptional target of p53: the −2934/−2905-bp region of the Rad promoter contains a p53-binding site required for p53-mediated transactivation. DNA damage induces Rad expression in a p53-dependent manner, with increased p53 occupancy and histone acetylation at the promoter. Rad expression in turn reduces inhibitory phosphorylation of cofilin at Ser3 (via ROK inhibition) and suppresses cancer cell migration and invasion. Rad knockdown promotes cell migration and abrogates p53-mediated migration suppression.","method":"Chromatin immunoprecipitation (ChIP), promoter-reporter assays with deletion and mutant constructs, siRNA knockdown, wound healing and Transwell invasion assays, co-filin phosphorylation western blot","journal":"Journal of molecular medicine (Berlin, Germany)","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — ChIP demonstrating direct p53 binding, promoter mutagenesis, and functional cell migration assays with KD, multiple orthogonal methods","pmids":["21221513"],"is_preprint":false},{"year":2011,"finding":"Rad inhibits cardiac fibrosis by directly binding to C/EBP-δ, thereby preventing C/EBP-δ from binding to the CTGF (connective tissue growth factor) promoter and suppressing CTGF expression. Rad-KO mice show increased cardiac fibrosis with elevated CTGF. In cardiomyocytes, Rad overexpression suppresses basal and TGF-β1-induced CTGF expression; conditioned medium from Rad-knockdown cardiomyocytes stimulates cardiac fibroblast ECM production, which is abolished by CTGF-neutralizing antibody.","method":"Rad-KO mice (Sirius Red staining), Western blot, adenoviral overexpression and RNAi knockdown, chromatin immunoprecipitation, co-immunoprecipitation, conditioned medium/neutralizing antibody experiments","journal":"Cardiovascular research","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct binding shown by co-IP, functional consequences in KO mice and cell-based systems with multiple orthogonal methods","pmids":["21382976"],"is_preprint":false},{"year":2013,"finding":"Genetic deletion of Rad in mice (Rad−/−) increases maximum L-type Ca2+ channel current (ICaL) with faster decay kinetics and lower activation voltage, elevates diastolic and twitch Ca2+ transients, and enhances sarcomere shortening, phenocopying β-adrenergic receptor stimulation without inducing cardiac hypertrophy. In isolated working hearts, +dP/dt was elevated at baseline with blunted response to further β-AR stimulation.","method":"Rad−/− mouse cardiomyocytes, patch-clamp electrophysiology, Fura-2 Ca2+ imaging, sarcomere shortening, isolated working heart preparations, echocardiography","journal":"Journal of the American Heart Association","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO model with rigorous electrophysiology, Ca2+ imaging, and contractility measurements in multiple preparations","pmids":["24334906"],"is_preprint":false},{"year":2014,"finding":"RRAD is a p53 transcriptional target that represses hypoxia-stimulated glycolysis in cancer cells. Ectopic RRAD expression reduces glycolysis and GLUT1 translocation to the plasma membrane; RRAD knockdown promotes glycolysis. Under hypoxia, p53 induces RRAD which in turn inhibits GLUT1 membrane translocation. siRNA knockdown of RRAD abolishes p53's ability to repress hypoxia-induced glycolysis.","method":"Ectopic expression and siRNA knockdown in lung cancer cells, glucose uptake assays, lactate production assays, GLUT1 subcellular fractionation and immunofluorescence, hypoxic conditions","journal":"Oncotarget","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal gain- and loss-of-function experiments with functional metabolic readouts and GLUT1 localization assays","pmids":["25114038"],"is_preprint":false},{"year":2014,"finding":"RRAD promotes EGFR-mediated STAT3 activation in glioblastoma by physically associating with EGFR and EEA1 (early endosome antigen 1), enhancing EGFR stability and endosome-associated nuclear translocation of EGFR, thereby activating STAT3 and stem cell factors.","method":"Co-immunoprecipitation (RRAD–EGFR, RRAD–EEA1), RRAD knockdown and overexpression in GBM cells, STAT3 phosphorylation assays, sphere formation assays, in vivo tumorigenesis","journal":"Molecular cancer therapeutics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP for binding, functional readouts with KD/OE, single lab study","pmids":["25313011"],"is_preprint":false},{"year":2015,"finding":"RRAD negatively regulates the Warburg effect in lung cancer cells by directly binding the p65 subunit of NF-κB and inhibiting nuclear translocation of p65, thereby reducing NF-κB-dependent GLUT1 membrane translocation and aerobic glycolysis. Blocking NF-κB signaling abolishes RRAD's inhibitory effects on GLUT1 translocation.","method":"Co-immunoprecipitation (RRAD–p65), nuclear fractionation assays for p65 translocation, NF-κB reporter assays, siRNA knockdown and overexpression in lung cancer cells, glucose uptake and lactate assays","journal":"Oncotarget","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct binding demonstrated by co-IP, functional cascade confirmed with NF-κB inhibitors and p65 fractionation, multiple orthogonal methods","pmids":["25893381"],"is_preprint":false},{"year":2019,"finding":"A rare RRAD missense variant (p.R211H), identified in a familial Brugada syndrome pedigree, causes reduced action potential upstroke velocity, prolonged action potentials, increased early afterdepolarizations, decreased Na+ peak current, increased Na+ persistent current, decreased L-type Ca2+ current, and abnormal actin distribution with fewer focal adhesions in iPSC-derived cardiomyocytes compared to intra-familial controls. Genome editing to introduce p.R211H into control iPSCs confirmed these defects.","method":"Whole-exome sequencing, iPSC-CMs from affected patients, patch-clamp electrophysiology, CRISPR genome editing, actin immunofluorescence, focal adhesion assays","journal":"European heart journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — CRISPR-confirmed variant with rigorous electrophysiology and structural readouts in human iPSC-CMs","pmids":["31114854"],"is_preprint":false},{"year":2019,"finding":"Myocardial-restricted inducible RAD knockout (RADΔ/Δ) mice show increased ICaL with β-AR-modulated phenotype at baseline, enhanced cytosolic Ca2+ handling, increased contractile function, elevated SERCA2a expression, and faster lusitropy, without structural cardiac remodeling or hypertrophy. This demonstrates that cardiac RAD ablation specifically enhances Ca2+ dynamics beneficially.","method":"Conditional inducible cardiac-specific Cre-lox KO, patch-clamp electrophysiology, Fura-2 Ca2+ transients, echocardiography, radiotelemetry, sarcomere shortening, Western blot","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — cardiac-specific KO distinguishing cardiac from systemic RAD effects, multiple orthogonal methods","pmids":["31147441"],"is_preprint":false},{"year":2019,"finding":"RRAD binds actin gamma 1 (ACTG1) and suppresses aerobic glycolysis in hepatocellular carcinoma through downregulation of ACTG1 expression; ACTG1 promotes HCC proliferation by regulating the cell cycle and inhibiting apoptosis via the mitochondrial pathway.","method":"Co-immunoprecipitation (RRAD–ACTG1), overexpression and knockdown in SK-Hep-1 and Huh7 cells, glycolysis/lactate assays, cell cycle analysis, apoptosis assays, in vivo xenograft","journal":"OncoTargets and therapy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP for binding partner, functional assays with gain/loss-of-function, single lab study","pmids":["30881024"],"is_preprint":false},{"year":2020,"finding":"Adrenergic CaV1.2 channel activation via Rad requires an intact rigid IS6-α-interaction domain helix in the α1C I-II loop and CaVβ binding to α1C. Introduction of polyglycine flexibility in the I-II loop eliminates β-adrenergic stimulation of CaV1.2 current despite intact CaVβ binding, placing the I-II loop structural rigidity as mechanistically essential for both Rad-mediated inhibition relief and β-AR regulation.","method":"Transgenic mice expressing α1C I-II loop mutants (GGG-α1C, exon9* variant, AID-binding mutants), patch-clamp electrophysiology in cardiomyocytes and heterologous systems, β-AR stimulation","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — transgenic mouse models with defined structural mutations and rigorous electrophysiology, multiple constructs in one study","pmids":["33086983"],"is_preprint":false},{"year":2021,"finding":"Rad is essential for PKA regulation of CaV1.2: reconstitution of the complete β-adrenergic receptor → PKA → CaV1.2 cascade in Xenopus oocytes demonstrates that ~80% of PKA-mediated CaV1.2 upregulation is Rad-dependent (requiring PKA phosphorylation of Rad) while ~20% is Rad-independent. β1-AR and β2-AR differ in the features of their CaV1.2 regulation in this system.","method":"Heterologous reconstitution in Xenopus oocytes with β1-AR or β2-AR, PKA, CaV1.2 subunits, and Rad; two-electrode voltage clamp electrophysiology; systematic pharmacological and genetic dissection","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — complete pathway reconstitution in defined heterologous system with rigorous dissection of Rad-dependent vs independent components","pmids":["34001616"],"is_preprint":false},{"year":2022,"finding":"Four PKA-phosphorylated residues in Rad are the primary mechanism underlying β-adrenergic augmentation of calcium influx in cardiomyocytes. Rad phosphosite-mutant (4SA-Rad) knock-in mice show reduced basal ICaL, near-complete attenuation of β-AR contractile response, reduced heart rate, and diminished exercise capacity. Expression of CaVβ-subunit mutants unable to bind 4SA-Rad restores basal Ca2+ influx and contractility to adrenergically augmented wild-type levels, rescuing the 4SA-Rad failing heart phenotype.","method":"4SA-Rad phosphosite knock-in mice, transgenic mice expressing Rad-binding-deficient CaVβ subunits, patch-clamp electrophysiology, echocardiography, exercise testing, cardiac function assays","journal":"Nature cardiovascular research","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — phosphosite knock-in mice combined with CaVβ rescue transgenic mice, rigorous electrophysiology and in vivo phenotyping, multiple orthogonal genetic strategies","pmids":["36424916"],"is_preprint":false},{"year":2018,"finding":"RRAD expression is upregulated in senescent cells across multiple senescence induction modes and acts as a negative regulator of cellular senescence by reducing reactive oxygen species levels. Both p53 and NF-κB bind to RRAD genomic regions and modulate RRAD transcription (co-activation by both factors).","method":"Pan-senescence transcriptome meta-analysis, validation in human fibroblasts (Ras-, H2O2-, ionizing radiation-, hydroxyurea-, etoposide-, replicative-induced senescence), ROS measurements, ChIP for p53 and NF-κB binding to RRAD locus","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — validated across six senescence modes with ChIP, but functional mechanism (ROS reduction) demonstrated in single lab study","pmids":["30391675"],"is_preprint":false},{"year":2001,"finding":"Rad promotes growth and tumorigenicity in breast cancer: stable transfection of Rad into Rad-negative MDA-MB435 breast cancer cells increases colony formation in soft agar and tumor growth rate in nude mice. Co-expression of nm23 inhibits these effects. Growth-promoting effects map to the N- and C-terminal regions of Rad rather than its GTPase domain.","method":"Stable transfection into breast cancer cell lines, soft agar colony formation, nude mouse xenograft, co-transfection with nm23, deletion/mutation analysis of Rad domains","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro and in vivo functional assays with domain mapping, single lab study","pmids":["11280768"],"is_preprint":false}],"current_model":"RRAD (RAD GTPase) is a small Ras-related GTPase that functions as an endogenous negative regulator of L-type voltage-gated Ca2+ channels (CaV1.2) by directly binding CaVβ subunits; PKA-mediated phosphorylation of four Rad residues is the primary mechanism by which β-adrenergic stimulation relieves Rad-dependent channel inhibition to augment cardiac contractility. Beyond Ca2+ channel regulation, Rad inhibits the Rho–Rho kinase pathway (via direct binding to ROK), is a direct transcriptional target of p53 and suppresses cell migration through cofilin/actin dynamics, represses aerobic glycolysis (Warburg effect) by binding p65-NF-κB to block GLUT1 membrane translocation, inhibits cardiac hypertrophy through the CaMKII pathway, and prevents cardiac fibrosis by binding C/EBP-δ to suppress CTGF expression; its GTPase activity is regulated by nm23 as a GAP, and phosphorylation by CaMKII, PKA, PKC, and CKII modulates its interaction with calmodulin and GTP binding."},"narrative":{"mechanistic_narrative":"RRAD (Rad) is a muscle-enriched, ~29 kDa Ras-related small GTPase that binds and hydrolyzes GTP and acts principally as an endogenous brake on L-type voltage-gated Ca2+ channels in the heart [PMID:8248782, PMID:7876254, PMID:14623965]. It inhibits CaV1.2 by binding directly to the channel's CaVβ accessory subunit, a requirement demonstrated by the selective inhibition of β-subunit-bearing channels and by nuclear sequestration of CaVβ when Rad is targeted to the nucleus [PMID:14623965, PMID:16298391]. Loss of Rad in cardiomyocytes raises ICaL, Ca2+ transients, SERCA2a, and contractility, phenocopying β-adrenergic stimulation without hypertrophy, identifying Rad as the central regulator of cardiac excitation–contraction coupling [PMID:19926875, PMID:24334906, PMID:31147441]. β-adrenergic/PKA signaling relieves this inhibition: PKA phosphorylation of four Rad residues accounts for the bulk of PKA-mediated CaV1.2 upregulation, and channel activation additionally requires structural rigidity of the α1C I-II loop and CaVβ binding [PMID:33086983, PMID:34001616, PMID:36424916]. A familial RRAD missense variant (p.R211H) causes Brugada-syndrome electrophysiological defects in iPSC-derived cardiomyocytes, linking the gene to inherited arrhythmia [PMID:31114854]. Rad activity is shaped by partner and post-translational inputs: nm23/NDP kinase serves as its GAP in a bidirectional interaction, calcium-dependent calmodulin and 14-3-3 binding govern its localization, and CaMKII, PKA, PKC, and CKII phosphorylate C-terminal serines to modulate CaM binding and GTP binding [PMID:9115241, PMID:9677319, PMID:10611312, PMID:16298391]. Beyond Ca2+ handling, Rad antagonizes the Rho/ROK pathway to drive stress-fiber and focal-adhesion disassembly and suppress cell migration, and it limits cardiac hypertrophy via CaMKII and cardiac fibrosis by binding C/EBP-δ to repress CTGF [PMID:11956230, PMID:15710763, PMID:18056528, PMID:21382976]. As a direct p53 transcriptional target, Rad restrains glycolysis by blocking GLUT1 membrane translocation (in part through binding NF-κB p65) and suppresses migration via cofilin/actin dynamics [PMID:21221513, PMID:25114038, PMID:25893381]. In skeletal muscle and adipocytes, Rad overexpression inhibits insulin-stimulated glucose uptake and worsens diet-induced insulin resistance in vivo [PMID:8798502, PMID:16537411].","teleology":[{"year":1993,"claim":"Established RRAD as a previously unknown small GTPase and tied its discovery to a disease context (overexpression in type II diabetic skeletal muscle), defining the gene to be studied.","evidence":"Subtraction cloning of human skeletal muscle cDNA and protein characterization","pmids":["8248782"],"confidence":"High","gaps":["No biochemical activity demonstrated","Causal role in diabetes not yet tested"]},{"year":1995,"claim":"Confirmed Rad is a functional GTP-binding protein with regulatable GTPase activity and a PKA-phosphorylated C-terminus, providing the biochemical scaffold for all downstream regulation.","evidence":"GST-fusion GTP/GDP binding and GTPase assays, mutagenesis, and in vitro PKA phosphorylation","pmids":["7876254"],"confidence":"High","gaps":["GAP identity unknown","Cellular consequences of GTP loading unknown"]},{"year":1996,"claim":"First linked Rad to the cytoskeleton and to glucose metabolism, showing nucleotide-dependent tropomyosin binding and inhibition of intrinsic glucose transporter activity.","evidence":"Co-IP, far-Western, fractionation, and glucose-uptake assays in muscle/fat cell lines","pmids":["8557685","8798502"],"confidence":"High","gaps":["Mechanism of transporter inhibition not resolved","In vivo relevance untested at this stage"]},{"year":1997,"claim":"Defined a calcium-sensing module: calcium-dependent calmodulin binding at the C-terminus and CaMKII as a kinase/partner, connecting Rad to Ca2+/calmodulin signaling.","evidence":"CaM-Sepharose pulldown, mutagenesis mapping, co-IP, and in vitro CaMKII assay","pmids":["9115241"],"confidence":"High","gaps":["Functional output of CaM binding not yet shown","Link to channel regulation not yet made"]},{"year":1998,"claim":"Mapped a multi-kinase phosphorylation code (CaMKII, PKA, PKC, CKII) controlling CaM interaction and GTP binding, establishing how signaling inputs tune Rad.","evidence":"In vitro kinase assays, phosphopeptide mapping, mutagenesis, GTP-binding and CaM pulldown assays","pmids":["9677319"],"confidence":"High","gaps":["Which phosphosites operate in vivo not defined here","Downstream effectors still unknown"]},{"year":1998,"claim":"Resolved how Rad associates with membranes/cytoskeleton, showing a non-lipid (non-prenylation, non-palmitoylation) mechanism distinct from canonical Ras targeting.","evidence":"Palmitate labeling, lovastatin treatment, Triton X-114 partitioning, deletion/chimera constructs in C2C12","pmids":["9683526"],"confidence":"High","gaps":["Precise targeting motif not pinpointed","Role of localization in function not yet tied to a substrate"]},{"year":1999,"claim":"Identified nm23/NDP kinase as the long-sought Rad GAP and revealed a reciprocal, bidirectional regulatory interaction controlling Rad's nucleotide state.","evidence":"GAP purification, immunodepletion, recombinant reconstitution, GTPase/NDP-kinase/autophosphorylation assays","pmids":["10611312"],"confidence":"High","gaps":["Physiological setting of the Rad–nm23 cycle unclear","GEF for Rad not identified"]},{"year":2002,"claim":"Placed Rad as a negative regulator of the Rho/ROK pathway, explaining its effects on actomyosin, stress fibers, and focal adhesions.","evidence":"Reciprocal co-IP, ROK kinase assays, deletion mapping, morphological assays in multiple cell lines","pmids":["11956230"],"confidence":"High","gaps":["Whether ROK binding is nucleotide-state dependent not fully defined","In vivo cardiovascular relevance not yet shown"]},{"year":2003,"claim":"Discovered Rad's defining activity—direct CaVβ binding and CaVβ-dependent abolition of L-type Ca2+ currents—establishing the RGK-channel inhibition paradigm.","evidence":"In vivo co-IP and whole-cell patch-clamp with CaV1.2/CaVβ in HEK293, plus deletion analysis","pmids":["14623965"],"confidence":"High","gaps":["Mechanism of current loss (trafficking vs gating) not resolved here","Endogenous cardiac relevance untested"]},{"year":2005,"claim":"Connected localization control (calmodulin/14-3-3) to channel regulation, showing Rad downregulates channels by preventing CaVβ surface expression including via nuclear sequestration.","evidence":"Fractionation, confocal imaging, co-IP, electrophysiology, nuclear-targeting constructs","pmids":["16298391"],"confidence":"High","gaps":["Relative contribution of nuclear sequestration vs other mechanisms in vivo unknown"]},{"year":2005,"claim":"Established Rad as a p53-induced, vasoprotective regulator that limits VSMC migration and neointima formation via Rho/ROK inhibition, with nucleotide-state dependence.","evidence":"Adenoviral delivery in rat carotid injury, RT-PCR, migration/adhesion assays, GDP/GTP mutants","pmids":["15710763"],"confidence":"High","gaps":["Direct p53 binding to promoter not yet shown here","Human disease relevance untested"]},{"year":2005,"claim":"Linked Rad transcription to myogenic and calcium-dependent programs, identifying MEF2/MyoD/Myf-5 and calcineurin/NFAT control of the Rad promoter.","evidence":"Microarray, promoter-reporter assays, calcineurin co-transfection, NFAT-motif mutagenesis in regenerating muscle","pmids":["16221735"],"confidence":"Medium","gaps":["Single-lab promoter study","Functional role of Rad in regeneration not directly tested"]},{"year":2006,"claim":"Provided in vivo proof that Rad negatively regulates muscle glucose metabolism, with muscle-specific overexpression worsening insulin resistance.","evidence":"MCK-Rad transgenic mice, glucose tolerance/insulin clamp, 2-DG uptake, lipoprotein lipase assays","pmids":["16537411"],"confidence":"High","gaps":["Molecular target mediating transporter inhibition unresolved","Loss-of-function metabolic phenotype not addressed"]},{"year":2007,"claim":"Defined an anti-hypertrophic role with Rad upstream of CaMKII, linking reduced cardiac Rad to human heart failure and hypertrophy.","evidence":"Human/mouse heart Western blots, adenoviral OE/RNAi, Rad-KO mice, pressure overload, CaMKII phosphorylation","pmids":["18056528"],"confidence":"High","gaps":["How Rad restrains CaMKII activation mechanistically unclear","Interplay with Ca2+ channel regulation not dissected"]},{"year":2009,"claim":"Demonstrated Rad as an endogenous bidirectional regulator of cardiac EC coupling and β-AR responsiveness via ICaL, moving the channel paradigm into native cardiomyocytes.","evidence":"Adenoviral OE and RNAi in rat cardiomyocytes, patch-clamp, Ca2+ imaging, sarcomere shortening, RadS105N","pmids":["19926875"],"confidence":"High","gaps":["Molecular link between Rad and β-AR signaling not yet defined","Phosphorylation control of relief untested"]},{"year":2011,"claim":"Established direct p53 binding to the Rad promoter and a p53→Rad→ROK/cofilin axis suppressing cancer cell migration and invasion.","evidence":"ChIP, promoter deletion/mutant reporters, siRNA, wound-healing/invasion assays, cofilin phosphorylation blots","pmids":["21221513"],"confidence":"High","gaps":["In vivo metastasis suppression not tested","Relative role of cofilin vs other ROK targets unclear"]},{"year":2011,"claim":"Identified an anti-fibrotic mechanism in which Rad binds C/EBP-δ to block CTGF transcription, with Rad-KO mice showing increased cardiac fibrosis.","evidence":"Rad-KO mice, ChIP, co-IP, adenoviral OE/RNAi, conditioned-medium/CTGF-neutralization experiments","pmids":["21382976"],"confidence":"High","gaps":["Whether C/EBP-δ binding depends on Rad nucleotide state unknown","Crosstalk with hypertrophy/EC-coupling roles unexplored"]},{"year":2013,"claim":"Showed that germline Rad deletion enhances ICaL, Ca2+ transients, and contractility, phenocopying β-AR stimulation without hypertrophy—cementing Rad as the cardiac channel brake.","evidence":"Rad−/− cardiomyocytes, patch-clamp, Fura-2 imaging, sarcomere shortening, working-heart preparations, echocardiography","pmids":["24334906"],"confidence":"High","gaps":["Systemic vs cardiac-intrinsic contribution not separated here","Mechanism of β-AR mimicry not molecularly defined"]},{"year":2014,"claim":"Established Rad as a p53 effector that represses hypoxic glycolysis by blocking GLUT1 membrane translocation, linking the gene to the Warburg effect.","evidence":"Ectopic expression/siRNA in lung cancer cells, glucose/lactate assays, GLUT1 fractionation and imaging under hypoxia","pmids":["25114038"],"confidence":"High","gaps":["Direct molecular target controlling GLUT1 not yet identified here","In vivo tumor metabolism untested"]},{"year":2014,"claim":"Described a context-dependent pro-tumor role in glioblastoma, where RRAD associates with EGFR and EEA1 to enhance EGFR stability and STAT3 activation.","evidence":"Co-IP (RRAD–EGFR, RRAD–EEA1), KD/OE in GBM cells, STAT3 assays, sphere formation, in vivo tumorigenesis","pmids":["25313011"],"confidence":"Medium","gaps":["Single-lab study","Reconciliation with tumor-suppressive roles elsewhere unresolved"]},{"year":2015,"claim":"Provided a molecular handle for glycolysis repression: RRAD binds NF-κB p65 to block its nuclear translocation and thereby GLUT1 surface expression.","evidence":"Co-IP (RRAD–p65), p65 fractionation, NF-κB reporter assays, siRNA/OE, glucose/lactate assays in lung cancer cells","pmids":["25893381"],"confidence":"High","gaps":["Whether p65 binding is direct and nucleotide-dependent unclear","Integration with p53 induction not dissected"]},{"year":2018,"claim":"Linked RRAD to cellular senescence as a ROS-lowering negative regulator co-activated by p53 and NF-κB across multiple senescence modes.","evidence":"Pan-senescence meta-analysis, validation in fibroblasts, ROS measurement, ChIP for p53 and NF-κB at the RRAD locus","pmids":["30391675"],"confidence":"Medium","gaps":["Mechanism of ROS reduction shown in single lab","Connection to GTPase activity untested"]},{"year":2019,"claim":"Linked RRAD to inherited arrhythmia by showing a familial p.R211H variant reproduces Brugada-syndrome electrophysiology and cytoskeletal defects in iPSC-cardiomyocytes.","evidence":"WES, patient and CRISPR-edited iPSC-CMs, patch-clamp, actin/focal-adhesion imaging","pmids":["31114854"],"confidence":"High","gaps":["Mechanistic basis of Na+ current changes incompletely defined","Genotype frequency/penetrance not established"]},{"year":2019,"claim":"Used cardiac-specific inducible KO to prove that heart-intrinsic Rad ablation beneficially enhances Ca2+ dynamics and contractility without remodeling, separating cardiac from systemic effects.","evidence":"Conditional cardiac Cre-lox KO, patch-clamp, Fura-2 transients, echocardiography, telemetry, Western blot","pmids":["31147441"],"confidence":"High","gaps":["Long-term consequences and therapeutic window not addressed","Molecular relief mechanism still pending phosphosite proof"]},{"year":2019,"claim":"Added a metabolic effector in hepatocellular carcinoma, with RRAD binding ACTG1 and suppressing glycolysis through ACTG1 downregulation.","evidence":"Co-IP (RRAD–ACTG1), OE/KD in HCC lines, glycolysis assays, cell cycle/apoptosis assays, xenografts","pmids":["30881024"],"confidence":"Medium","gaps":["Single-lab study","How RRAD downregulates ACTG1 mechanistically unclear"]},{"year":2020,"claim":"Defined the structural requirement on the channel side, showing the α1C I-II loop rigidity and CaVβ binding are essential for Rad-mediated inhibition relief and β-AR regulation.","evidence":"Transgenic mice with α1C I-II loop mutants, patch-clamp in cardiomyocytes and heterologous systems, β-AR stimulation","pmids":["33086983"],"confidence":"High","gaps":["Atomic-level structure of the Rad–CaVβ–α1C complex not resolved","Conformational changes upon phosphorylation not visualized"]},{"year":2021,"claim":"Demonstrated by full pathway reconstitution that Rad is the dominant (~80%) mediator of PKA-driven CaV1.2 upregulation, requiring PKA phosphorylation of Rad.","evidence":"Xenopus oocyte reconstitution of β-AR→PKA→CaV1.2 with two-electrode voltage clamp and genetic dissection","pmids":["34001616"],"confidence":"High","gaps":["Identity of the residual Rad-independent component unresolved","In vivo confirmation of phosphosite necessity pending"]},{"year":2022,"claim":"Provided definitive in vivo proof that four PKA phosphosites in Rad mediate β-adrenergic augmentation of cardiac Ca2+ influx, with CaVβ-binding-deficient mutants rescuing the phosphosite-mutant heart.","evidence":"4SA-Rad knock-in mice plus Rad-binding-deficient CaVβ transgenics, patch-clamp, echocardiography, exercise testing","pmids":["36424916"],"confidence":"High","gaps":["Spatial/structural mechanism of phosphorylation-induced unbinding not visualized","Therapeutic targeting of this node untested"]},{"year":null,"claim":"How Rad's GTPase cycle, calmodulin/14-3-3-controlled localization, and PKA phosphorylation are integrated structurally to release CaVβ, and how the gene's many cancer/metabolic roles are reconciled with its cardiac function, remain open.","evidence":"No single study in the timeline unifies the structural, biochemical, and physiological mechanisms","pmids":[],"confidence":"Low","gaps":["No atomic structure of the Rad–CaVβ complex in the corpus","GEF for Rad unidentified","Context-dependent pro- vs anti-tumor roles unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003924","term_label":"GTPase activity","supporting_discovery_ids":[1,7]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[9,15,26,27]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[17,21]}],"localization":[{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[2,6]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[6,9,10]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[10]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[6]}],"pathway":[{"term_id":"R-HSA-397014","term_label":"Muscle contraction","supporting_discovery_ids":[15,18,23,27]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[8,26,27]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[3,13,19,21]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[16,28]}],"complexes":[],"partners":["CACNB2","CALM1","NME1","ROCK1","ROCK2","RELA","CEBPD","EGFR"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P55042","full_name":"GTP-binding protein RAD","aliases":["RAD1","Ras associated with diabetes"],"length_aa":308,"mass_kda":33.2,"function":"May regulate basal voltage-dependent L-type Ca(2+) currents and be required for beta-adrenergic augmentation of Ca(2+) influx in cardiomyocytes, thereby regulating increases in heart rate and contractile force (By similarity). May play an important role in cardiac antiarrhythmia via the strong suppression of voltage-gated L-type Ca(2+) currents (By similarity). Regulates voltage-dependent L-type calcium channel subunit alpha-1C trafficking to the cell membrane (By similarity). Inhibits cardiac hypertrophy through the calmodulin-dependent kinase II (CaMKII) pathway (PubMed:18056528). Inhibits phosphorylation and activation of CAMK2D (PubMed:18056528)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P55042/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RRAD","classification":"Not Classified","n_dependent_lines":68,"n_total_lines":1208,"dependency_fraction":0.056291390728476824},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/RRAD","total_profiled":1310},"omim":[{"mim_id":"616955","title":"RRAD- AND GEM-LIKE GTPase 2; REM2","url":"https://www.omim.org/entry/616955"},{"mim_id":"610388","title":"RRAD- AND GEM-LIKE GTPase 1; REM1","url":"https://www.omim.org/entry/610388"},{"mim_id":"179503","title":"RRAD RAS-RELATED GLYCOLYSIS INHIBITOR AND CALCIUM CHANNEL REGULATOR; RRAD","url":"https://www.omim.org/entry/179503"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"},{"location":"Nucleoplasm","reliability":"Additional"},{"location":"Golgi apparatus","reliability":"Additional"},{"location":"Flagellar centriole","reliability":"Additional"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"heart muscle","ntpm":316.2},{"tissue":"skeletal muscle","ntpm":776.8}],"url":"https://www.proteinatlas.org/search/RRAD"},"hgnc":{"alias_symbol":["REM3","RAD"],"prev_symbol":[]},"alphafold":{"accession":"P55042","domains":[{"cath_id":"3.40.50.300","chopping":"91-258","consensus_level":"high","plddt":91.7269,"start":91,"end":258}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P55042","model_url":"https://alphafold.ebi.ac.uk/files/AF-P55042-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P55042-F1-predicted_aligned_error_v6.png","plddt_mean":73.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RRAD","jax_strain_url":"https://www.jax.org/strain/search?query=RRAD"},"sequence":{"accession":"P55042","fasta_url":"https://rest.uniprot.org/uniprotkb/P55042.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P55042/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P55042"}},"corpus_meta":[{"pmid":"17189378","id":"PMC_17189378","title":"Rapid and cost-effective polymorphism identification and genotyping using restriction site associated DNA (RAD) markers.","date":"2006","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/17189378","citation_count":589,"is_preprint":false},{"pmid":"8497322","id":"PMC_8497322","title":"Fission yeast chk1 protein kinase links the rad checkpoint pathway to cdc2.","date":"1993","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8497322","citation_count":417,"is_preprint":false},{"pmid":"8553071","id":"PMC_8553071","title":"rad-dependent response of the chk1-encoded protein kinase at the DNA damage checkpoint.","date":"1996","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/8553071","citation_count":367,"is_preprint":false},{"pmid":"8248782","id":"PMC_8248782","title":"Rad: a member of the Ras family overexpressed in muscle of type II diabetic humans.","date":"1993","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/8248782","citation_count":287,"is_preprint":false},{"pmid":"26715661","id":"PMC_26715661","title":"RAD Capture (Rapture): Flexible and Efficient Sequence-Based Genotyping.","date":"2015","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26715661","citation_count":256,"is_preprint":false},{"pmid":"17248996","id":"PMC_17248996","title":"The Role of Radiation (rad) Genes in Meiotic Recombination in Yeast.","date":"1980","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17248996","citation_count":233,"is_preprint":false},{"pmid":"7768886","id":"PMC_7768886","title":"Reconstitution of yeast nucleotide excision repair with purified Rad proteins, replication protein A, and transcription factor TFIIH.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7768886","citation_count":209,"is_preprint":false},{"pmid":"22493668","id":"PMC_22493668","title":"Inferring phylogenies from RAD sequence data.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22493668","citation_count":202,"is_preprint":false},{"pmid":"12684824","id":"PMC_12684824","title":"Genetic and cytological characterization of the recombination protein RAD-51 in Caenorhabditis elegans.","date":"2003","source":"Chromosoma","url":"https://pubmed.ncbi.nlm.nih.gov/12684824","citation_count":196,"is_preprint":false},{"pmid":"25657328","id":"PMC_25657328","title":"Restriction Site-Associated DNA Sequencing (RAD-seq) Reveals an Extraordinary Number of Transitions among Gecko Sex-Determining Systems.","date":"2015","source":"Molecular biology and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/25657328","citation_count":189,"is_preprint":false},{"pmid":"14623965","id":"PMC_14623965","title":"Regulation of voltage-gated calcium channel activity by the Rem and Rad GTPases.","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/14623965","citation_count":187,"is_preprint":false},{"pmid":"21205322","id":"PMC_21205322","title":"Construction and application for QTL analysis of a Restriction Site Associated DNA (RAD) linkage map in barley.","date":"2011","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/21205322","citation_count":183,"is_preprint":false},{"pmid":"11572977","id":"PMC_11572977","title":"Purification and characterization of human DNA damage checkpoint Rad complexes.","date":"2001","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11572977","citation_count":164,"is_preprint":false},{"pmid":"7800045","id":"PMC_7800045","title":"DNA structure-dependent requirements for yeast RAD genes in gene conversion.","date":"1995","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/7800045","citation_count":158,"is_preprint":false},{"pmid":"11956230","id":"PMC_11956230","title":"The GTP binding proteins Gem and Rad are negative regulators of the Rho-Rho kinase pathway.","date":"2002","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11956230","citation_count":153,"is_preprint":false},{"pmid":"25319241","id":"PMC_25319241","title":"Demystifying the RAD fad.","date":"2014","source":"Molecular ecology","url":"https://pubmed.ncbi.nlm.nih.gov/25319241","citation_count":140,"is_preprint":false},{"pmid":"15798199","id":"PMC_15798199","title":"RAD-51-dependent and -independent roles of a Caenorhabditis elegans BRCA2-related protein during DNA double-strand break repair.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15798199","citation_count":139,"is_preprint":false},{"pmid":"11747819","id":"PMC_11747819","title":"C. elegans RAD-5/CLK-2 defines a new DNA damage checkpoint protein.","date":"2001","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/11747819","citation_count":133,"is_preprint":false},{"pmid":"8690802","id":"PMC_8690802","title":"Acute regulation by insulin of phosphatidylinositol-3-kinase, Rad, Glut 4, and lipoprotein lipase mRNA levels in human muscle.","date":"1996","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/8690802","citation_count":120,"is_preprint":false},{"pmid":"21663628","id":"PMC_21663628","title":"Identification of SNP and SSR markers in eggplant using RAD tag sequencing.","date":"2011","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/21663628","citation_count":114,"is_preprint":false},{"pmid":"11861554","id":"PMC_11861554","title":"Roles for Caenorhabditis elegans rad-51 in meiosis and in resistance to ionizing radiation during development.","date":"2002","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11861554","citation_count":110,"is_preprint":false},{"pmid":"8798502","id":"PMC_8798502","title":"Overexpression of Rad inhibits glucose uptake in cultured muscle and fat cells.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8798502","citation_count":108,"is_preprint":false},{"pmid":"10611312","id":"PMC_10611312","title":"Interaction of the Ras-related protein associated with diabetes rad and the putative tumor metastasis suppressor NM23 provides a novel mechanism of GTPase regulation.","date":"1999","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10611312","citation_count":108,"is_preprint":false},{"pmid":"30551670","id":"PMC_30551670","title":"RAD-ical New Insights into RAD51 Regulation.","date":"2018","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/30551670","citation_count":105,"is_preprint":false},{"pmid":"19182205","id":"PMC_19182205","title":"Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom).","date":"2009","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/19182205","citation_count":103,"is_preprint":false},{"pmid":"24828244","id":"PMC_24828244","title":"Sequencing degraded DNA from non-destructively sampled museum specimens for RAD-tagging and low-coverage shotgun phylogenetics.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24828244","citation_count":100,"is_preprint":false},{"pmid":"9268335","id":"PMC_9268335","title":"Rem is a new member of the Rad- and Gem/Kir Ras-related GTP-binding protein family repressed by lipopolysaccharide stimulation.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9268335","citation_count":92,"is_preprint":false},{"pmid":"9115241","id":"PMC_9115241","title":"Rad and Rad-related GTPases interact with calmodulin and calmodulin-dependent protein kinase II.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9115241","citation_count":87,"is_preprint":false},{"pmid":"16298391","id":"PMC_16298391","title":"Nuclear sequestration of beta-subunits by Rad and Rem is controlled by 14-3-3 and calmodulin and reveals a novel mechanism for Ca2+ channel regulation.","date":"2005","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16298391","citation_count":86,"is_preprint":false},{"pmid":"25114038","id":"PMC_25114038","title":"Tumor suppressor p53 negatively regulates glycolysis stimulated by hypoxia through its target RRAD.","date":"2014","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25114038","citation_count":83,"is_preprint":false},{"pmid":"20122407","id":"PMC_20122407","title":"Overlapping mechanisms promote postsynaptic RAD-51 filament disassembly during meiotic double-strand break repair.","date":"2010","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/20122407","citation_count":83,"is_preprint":false},{"pmid":"11280768","id":"PMC_11280768","title":"Regulation of growth and tumorigenicity of breast cancer cells by the low molecular weight GTPase Rad and nm23.","date":"2001","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/11280768","citation_count":83,"is_preprint":false},{"pmid":"21991593","id":"PMC_21991593","title":"RAD in the realm of next-generation sequencing technologies.","date":"2011","source":"Molecular ecology","url":"https://pubmed.ncbi.nlm.nih.gov/21991593","citation_count":82,"is_preprint":false},{"pmid":"24497030","id":"PMC_24497030","title":"Empirical assessment of RAD sequencing for interspecific phylogeny.","date":"2014","source":"Molecular biology and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/24497030","citation_count":80,"is_preprint":false},{"pmid":"18056528","id":"PMC_18056528","title":"Rad GTPase deficiency leads to cardiac hypertrophy.","date":"2007","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/18056528","citation_count":76,"is_preprint":false},{"pmid":"22702806","id":"PMC_22702806","title":"Characterisation of QTL-linked and genome-wide restriction site-associated DNA (RAD) markers in farmed Atlantic salmon.","date":"2012","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/22702806","citation_count":76,"is_preprint":false},{"pmid":"8744945","id":"PMC_8744945","title":"Distinct roles of yeast MEC and RAD checkpoint genes in transcriptional induction after DNA damage and implications for function.","date":"1996","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/8744945","citation_count":76,"is_preprint":false},{"pmid":"23181719","id":"PMC_23181719","title":"Mapping phenotypic, expression and transmission ratio distortion QTL using RAD markers in the Lake Whitefish (Coregonus clupeaformis).","date":"2012","source":"Molecular ecology","url":"https://pubmed.ncbi.nlm.nih.gov/23181719","citation_count":74,"is_preprint":false},{"pmid":"10708101","id":"PMC_10708101","title":"SDZ-RAD prevents manifestation of chronic rejection in rat renal allografts.","date":"2000","source":"Transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/10708101","citation_count":72,"is_preprint":false},{"pmid":"22942077","id":"PMC_22942077","title":"Rainbow: an integrated tool for efficient clustering and assembling RAD-seq reads.","date":"2012","source":"Bioinformatics (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22942077","citation_count":64,"is_preprint":false},{"pmid":"19267542","id":"PMC_19267542","title":"Radiation protection by a new chemical entity, Ex-Rad: efficacy and mechanisms.","date":"2009","source":"Radiation research","url":"https://pubmed.ncbi.nlm.nih.gov/19267542","citation_count":64,"is_preprint":false},{"pmid":"19926875","id":"PMC_19926875","title":"Rad as a novel regulator of excitation-contraction coupling and beta-adrenergic signaling in heart.","date":"2009","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/19926875","citation_count":63,"is_preprint":false},{"pmid":"22843617","id":"PMC_22843617","title":"Amelioration of radiation-induced hematopoietic and gastrointestinal damage by Ex-RAD(R) in mice.","date":"2012","source":"Journal of radiation research","url":"https://pubmed.ncbi.nlm.nih.gov/22843617","citation_count":62,"is_preprint":false},{"pmid":"17672842","id":"PMC_17672842","title":"Diversification and co-option of RAD-like genes in the evolution of floral asymmetry.","date":"2007","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17672842","citation_count":59,"is_preprint":false},{"pmid":"16843491","id":"PMC_16843491","title":"CeBRC-2 stimulates D-loop formation by RAD-51 and promotes DNA single-strand annealing.","date":"2006","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16843491","citation_count":55,"is_preprint":false},{"pmid":"7876254","id":"PMC_7876254","title":"Characterization of Rad, a new member of Ras/GTPase superfamily, and its regulation by a unique GTPase-activating protein (GAP)-like activity.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7876254","citation_count":55,"is_preprint":false},{"pmid":"17483448","id":"PMC_17483448","title":"Stabilization of RAD-51-DNA filaments via an interaction domain in Caenorhabditis elegans BRCA2.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17483448","citation_count":54,"is_preprint":false},{"pmid":"8557685","id":"PMC_8557685","title":"Rad, a novel Ras-related GTPase, interacts with skeletal muscle beta-tropomyosin.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8557685","citation_count":52,"is_preprint":false},{"pmid":"24334906","id":"PMC_24334906","title":"Rad GTPase deletion increases L-type calcium channel current leading to increased cardiac contraction.","date":"2013","source":"Journal of the American Heart Association","url":"https://pubmed.ncbi.nlm.nih.gov/24334906","citation_count":52,"is_preprint":false},{"pmid":"30383754","id":"PMC_30383754","title":"BRCA1-BARD1 associate with the synaptonemal complex and pro-crossover factors and influence RAD-51 dynamics during Caenorhabditis elegans meiosis.","date":"2018","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30383754","citation_count":50,"is_preprint":false},{"pmid":"21382976","id":"PMC_21382976","title":"Rad GTPase inhibits cardiac fibrosis through connective tissue growth factor.","date":"2011","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/21382976","citation_count":47,"is_preprint":false},{"pmid":"36424916","id":"PMC_36424916","title":"Rad regulation of CaV1.2 channels controls cardiac fight-or-flight response.","date":"2022","source":"Nature cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/36424916","citation_count":46,"is_preprint":false},{"pmid":"8413238","id":"PMC_8413238","title":"Human ERCC5 cDNA-cosmid complementation for excision repair and bipartite amino acid domains conserved with RAD proteins of Saccharomyces cerevisiae and Schizosaccharomyces pombe.","date":"1993","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8413238","citation_count":46,"is_preprint":false},{"pmid":"33086983","id":"PMC_33086983","title":"Adrenergic CaV1.2 Activation via Rad Phosphorylation Converges at α1C I-II Loop.","date":"2020","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/33086983","citation_count":44,"is_preprint":false},{"pmid":"24661439","id":"PMC_24661439","title":"Transient protein-protein interface prediction: datasets, features, algorithms, and the RAD-T predictor.","date":"2014","source":"BMC bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/24661439","citation_count":44,"is_preprint":false},{"pmid":"18053776","id":"PMC_18053776","title":"Nucleotide excision repair and the degradation of RNA pol II by the Caenorhabditis elegans XPA and Rsp5 orthologues, RAD-3 and WWP-1.","date":"2007","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/18053776","citation_count":44,"is_preprint":false},{"pmid":"31114854","id":"PMC_31114854","title":"RRAD mutation causes electrical and cytoskeletal defects in cardiomyocytes derived from a familial case of Brugada syndrome.","date":"2019","source":"European heart journal","url":"https://pubmed.ncbi.nlm.nih.gov/31114854","citation_count":43,"is_preprint":false},{"pmid":"27213697","id":"PMC_27213697","title":"Using RAD-seq to recognize sex-specific markers and sex chromosome systems.","date":"2016","source":"Molecular ecology","url":"https://pubmed.ncbi.nlm.nih.gov/27213697","citation_count":42,"is_preprint":false},{"pmid":"22487779","id":"PMC_22487779","title":"Promoter hypermethylation of Ras-related GTPase gene RRAD inactivates a tumor suppressor function in nasopharyngeal carcinoma.","date":"2012","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/22487779","citation_count":41,"is_preprint":false},{"pmid":"14500819","id":"PMC_14500819","title":"The human checkpoint Rad protein Rad17 is chromatin-associated throughout the cell cycle, localizes to DNA replication sites, and interacts with DNA polymerase epsilon.","date":"2003","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/14500819","citation_count":41,"is_preprint":false},{"pmid":"16537411","id":"PMC_16537411","title":"Overexpression of Rad in muscle worsens diet-induced insulin resistance and glucose intolerance and lowers plasma triglyceride level.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16537411","citation_count":40,"is_preprint":false},{"pmid":"15710763","id":"PMC_15710763","title":"Rad GTPase attenuates vascular lesion formation by inhibition of vascular smooth muscle cell migration.","date":"2005","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/15710763","citation_count":39,"is_preprint":false},{"pmid":"27286653","id":"PMC_27286653","title":"RAD-seq derived genome-wide nuclear markers resolve the phylogeny of tunas.","date":"2016","source":"Molecular phylogenetics and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/27286653","citation_count":39,"is_preprint":false},{"pmid":"28029651","id":"PMC_28029651","title":"The pseudogene DUXAP10 promotes an aggressive phenotype through binding with LSD1 and repressing LATS2 and RRAD in non small cell lung cancer.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28029651","citation_count":38,"is_preprint":false},{"pmid":"24479409","id":"PMC_24479409","title":"Selective intra-arterial infusion of rAd-p53 with chemotherapy for advanced oral cancer: a randomized clinical trial.","date":"2014","source":"BMC medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24479409","citation_count":37,"is_preprint":false},{"pmid":"25313011","id":"PMC_25313011","title":"RRAD promotes EGFR-mediated STAT3 activation and induces temozolomide resistance of malignant glioblastoma.","date":"2014","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/25313011","citation_count":36,"is_preprint":false},{"pmid":"10831614","id":"PMC_10831614","title":"Ges, A human GTPase of the Rad/Gem/Kir family, promotes endothelial cell sprouting and cytoskeleton reorganization.","date":"2000","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10831614","citation_count":36,"is_preprint":false},{"pmid":"32506034","id":"PMC_32506034","title":"Simultaneous aerobic denitrification and antibiotics degradation by strain Marinobacter hydrocarbonoclasticus RAD-2.","date":"2020","source":"Bioresource technology","url":"https://pubmed.ncbi.nlm.nih.gov/32506034","citation_count":36,"is_preprint":false},{"pmid":"25893381","id":"PMC_25893381","title":"RRAD inhibits the Warburg effect through negative regulation of the NF-κB signaling.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25893381","citation_count":34,"is_preprint":false},{"pmid":"25496374","id":"PMC_25496374","title":"Key points of basic theories and clinical practice in rAd-p53 ( Gendicine ™) gene therapy for solid malignant tumors.","date":"2014","source":"Expert opinion on biological therapy","url":"https://pubmed.ncbi.nlm.nih.gov/25496374","citation_count":32,"is_preprint":false},{"pmid":"9677319","id":"PMC_9677319","title":"Effects of phosphorylation on function of the Rad GTPase.","date":"1998","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/9677319","citation_count":32,"is_preprint":false},{"pmid":"31147441","id":"PMC_31147441","title":"Myocardial-restricted ablation of the GTPase RAD results in a pro-adaptive heart response in mice.","date":"2019","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31147441","citation_count":32,"is_preprint":false},{"pmid":"32142201","id":"PMC_32142201","title":"Estimating and accounting for genotyping errors in RAD-seq experiments.","date":"2020","source":"Molecular ecology resources","url":"https://pubmed.ncbi.nlm.nih.gov/32142201","citation_count":31,"is_preprint":false},{"pmid":"26139514","id":"PMC_26139514","title":"RAD mapping reveals an evolving, polymorphic and fuzzy boundary of a plant pseudoautosomal region.","date":"2015","source":"Molecular ecology","url":"https://pubmed.ncbi.nlm.nih.gov/26139514","citation_count":31,"is_preprint":false},{"pmid":"15064772","id":"PMC_15064772","title":"The rapamycin derivative RAD inhibits mesangial cell migration through the CDK-inhibitor p27KIP1.","date":"2004","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/15064772","citation_count":31,"is_preprint":false},{"pmid":"37117195","id":"PMC_37117195","title":"Leveraging the microbiome to understand clinical heterogeneity in depression: findings from the T-RAD study.","date":"2023","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/37117195","citation_count":31,"is_preprint":false},{"pmid":"24648519","id":"PMC_24648519","title":"Ras-induced epigenetic inactivation of the RRAD (Ras-related associated with diabetes) gene promotes glucose uptake in a human ovarian cancer model.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24648519","citation_count":30,"is_preprint":false},{"pmid":"30881024","id":"PMC_30881024","title":"RRAD suppresses the Warburg effect by downregulating ACTG1 in hepatocellular carcinoma.","date":"2019","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30881024","citation_count":29,"is_preprint":false},{"pmid":"30419821","id":"PMC_30419821","title":"RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation.","date":"2018","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/30419821","citation_count":28,"is_preprint":false},{"pmid":"9683526","id":"PMC_9683526","title":"The ras-related protein rad associates with the cytoskeleton in a non-lipid-dependent manner.","date":"1998","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/9683526","citation_count":28,"is_preprint":false},{"pmid":"26181055","id":"PMC_26181055","title":"Identification of Laying-Related SNP Markers in Geese Using RAD Sequencing.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26181055","citation_count":27,"is_preprint":false},{"pmid":"25808755","id":"PMC_25808755","title":"Double-digest RAD sequencing using Ion Proton semiconductor platform (ddRADseq-ion) with nonmodel organisms.","date":"2015","source":"Molecular ecology resources","url":"https://pubmed.ncbi.nlm.nih.gov/25808755","citation_count":27,"is_preprint":false},{"pmid":"26936927","id":"PMC_26936927","title":"Promotion of Homologous Recombination by SWS-1 in Complex with RAD-51 Paralogs in Caenorhabditis elegans.","date":"2016","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26936927","citation_count":26,"is_preprint":false},{"pmid":"16221735","id":"PMC_16221735","title":"Rad is temporally regulated within myogenic progenitor cells during skeletal muscle regeneration.","date":"2005","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16221735","citation_count":25,"is_preprint":false},{"pmid":"16968694","id":"PMC_16968694","title":"Ras triggers ataxia-telangiectasia-mutated and Rad-3-related activation and apoptosis through sustained mitogenic signaling.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16968694","citation_count":25,"is_preprint":false},{"pmid":"26490867","id":"PMC_26490867","title":"Loss of RAD-23 Protects Against Models of Motor Neuron Disease by Enhancing Mutant Protein Clearance.","date":"2015","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26490867","citation_count":25,"is_preprint":false},{"pmid":"31839825","id":"PMC_31839825","title":"HPV 16 E6/E7 up-regulate the expression of both HIF-1α and GLUT1 by inhibition of RRAD and activation of NF-κB in lung cancer cells.","date":"2019","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/31839825","citation_count":24,"is_preprint":false},{"pmid":"29244155","id":"PMC_29244155","title":"Differential RPA-1 and RAD-51 recruitment in vivo throughout the C. elegans germline, as revealed by laser microirradiation.","date":"2018","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/29244155","citation_count":24,"is_preprint":false},{"pmid":"30032645","id":"PMC_30032645","title":"Oncolytic Adenovirus rAd.DCN Inhibits Breast Tumor Growth and Lung Metastasis in an Immune-Competent Orthotopic Xenograft Model.","date":"2018","source":"Human gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30032645","citation_count":24,"is_preprint":false},{"pmid":"9259545","id":"PMC_9259545","title":"DNA repair: RAD alert.","date":"1997","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/9259545","citation_count":23,"is_preprint":false},{"pmid":"21221513","id":"PMC_21221513","title":"Rad is a p53 direct transcriptional target that inhibits cell migration and is frequently silenced in lung carcinoma cells.","date":"2011","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/21221513","citation_count":23,"is_preprint":false},{"pmid":"11147698","id":"PMC_11147698","title":"The novel immunosuppressant FTY720 induces peripheral lymphodepletion of both T- and B-cells in cynomolgus monkeys when given alone, with Cyclosporine Neoral or with RAD.","date":"2000","source":"Transplant immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11147698","citation_count":23,"is_preprint":false},{"pmid":"30391675","id":"PMC_30391675","title":"Pan-senescence transcriptome analysis identified RRAD as a marker and negative regulator of cellular senescence.","date":"2018","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30391675","citation_count":21,"is_preprint":false},{"pmid":"22090785","id":"PMC_22090785","title":"rAd-p53 enhances the sensitivity of human gastric cancer cells to chemotherapy.","date":"2011","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/22090785","citation_count":21,"is_preprint":false},{"pmid":"27798760","id":"PMC_27798760","title":"Rad-deletion Phenocopies Tonic Sympathetic Stimulation of the Heart.","date":"2016","source":"Journal of cardiovascular translational research","url":"https://pubmed.ncbi.nlm.nih.gov/27798760","citation_count":20,"is_preprint":false},{"pmid":"33532827","id":"PMC_33532827","title":"RAD: a web application to identify region associated differentially expressed genes.","date":"2021","source":"Bioinformatics (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/33532827","citation_count":20,"is_preprint":false},{"pmid":"11146509","id":"PMC_11146509","title":"Identification and characterization of newt rad (ras associated with diabetes), a gene specifically expressed in regenerating limb muscle.","date":"2001","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/11146509","citation_count":20,"is_preprint":false},{"pmid":"37117218","id":"PMC_37117218","title":"RAD-TGTs: high-throughput measurement of cellular mechanotype via rupture and delivery of DNA tension probes.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37117218","citation_count":19,"is_preprint":false},{"pmid":"30583719","id":"PMC_30583719","title":"ddSeeker: a tool for processing Bio-Rad ddSEQ single cell RNA-seq data.","date":"2018","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/30583719","citation_count":19,"is_preprint":false},{"pmid":"34001616","id":"PMC_34001616","title":"Reconstitution of β-adrenergic regulation of CaV1.2: Rad-dependent and Rad-independent protein kinase A mechanisms.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/34001616","citation_count":18,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49763,"output_tokens":8585,"usd":0.139032,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18694,"output_tokens":7934,"usd":0.14591,"stage2_stop_reason":"end_turn"},"total_usd":0.284942,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"RRAD (Rad) was identified as a new ~29 kDa member of the Ras-GTPase superfamily, overexpressed in skeletal muscle of type II diabetic humans, establishing it as a novel small GTPase expressed primarily in skeletal and cardiac muscle.\",\n      \"method\": \"Subtraction cloning of human skeletal muscle cDNA libraries, followed by molecular characterization of the encoded protein\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — original identification paper using direct molecular cloning and characterization, foundational discovery replicated in subsequent work\",\n      \"pmids\": [\"8248782\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Rad binds GTP in a specific and saturable manner, has low intrinsic GTPase activity that is enhanced by a tissue-specific GAP activity distinct from known Ras-GAPs, and is phosphorylated in vitro by PKA at two C-terminal sites. GDP binding is lost with the S66N mutation (equivalent to Ras position 12).\",\n      \"method\": \"Bacterial GST-fusion protein expression, GTP/GDP binding assays, GTPase activity assays, site-directed mutagenesis, in vitro phosphorylation with PKA, phosphopeptide mapping\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple in vitro biochemical assays with mutagenesis in a single rigorous study\",\n      \"pmids\": [\"7876254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Rad interacts with skeletal muscle beta-tropomyosin; this interaction is guanine nucleotide-dependent (GDP-Rad binds tropomyosin better than GTP-Rad) and is enhanced by calcium ionophore A23187. Calcium promotes Rad association with the cytoskeletal fraction in C2C12 cells.\",\n      \"method\": \"Expression screening of cDNA libraries, co-immunoprecipitation in C2C12 cells, calcium ionophore treatment, far-Western blotting, guanine nucleotide saturation studies, subcellular fractionation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods (library screen, co-IP, far-Western, fractionation) establishing binding partner and nucleotide-state dependence\",\n      \"pmids\": [\"8557685\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Overexpression of Rad in C2C12 myotubes, L6 myotubes, and 3T3-L1 adipocytes reduces insulin-stimulated glucose uptake by 50–90% without altering GLUT4 expression, GLUT4 translocation, or insulin receptor/IRS-1 phosphorylation or PI3-kinase activity, suggesting Rad inhibits intrinsic transporter activity.\",\n      \"method\": \"Stable and transient overexpression in muscle and fat cell lines, 2-deoxyglucose and 3-O-methylglucose uptake assays, GLUT4 immunofluorescence, Western blot for signaling intermediates, PI3-kinase assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean overexpression with multiple orthogonal functional readouts across three cell lines\",\n      \"pmids\": [\"8798502\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Rad and Gem bind calmodulin (CaM) in a calcium-dependent manner; the binding site maps to residues 278–297 at the Rad C-terminus, which contains a canonical CaM-binding motif. GDP-bound Rad shows ~5-fold better CaM binding than GTP-bound Rad. Rad co-immunoprecipitates with CaMKII in C2C12 cells, and both Rad and Gem serve as CaMKII substrates in vitro. An extended N-terminal domain negatively regulates CaM binding.\",\n      \"method\": \"CaM-Sepharose pulldown, co-immunoprecipitation, deletion and point mutant analysis, in vitro CaMKII kinase assay, subcellular fractionation correlating CaM binding with cytoskeletal localization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — reconstitution (CaM pulldown), mutagenesis mapping, co-IP, and in vitro kinase assay in single study with multiple orthogonal methods\",\n      \"pmids\": [\"9115241\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Rad is phosphorylated by CaMKII and PKA at Ser273, and by PKC and CKII at multiple C-terminal serines (Ser214, Ser257, Ser273, Ser290, Ser299). Phosphorylation by PKC and CKII abolishes Rad–calmodulin interaction. PKA incubation decreases GTP binding (~60–70%) independently of Ser273 phosphorylation.\",\n      \"method\": \"In vitro kinase assays with PKA, CaMKII, PKC, CKII; deletion and point mutagenesis; phosphopeptide mapping; GTP binding assays; CaM-Sepharose pulldown\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — systematic mutagenesis combined with multiple in vitro kinase assays and functional readouts in single rigorous study\",\n      \"pmids\": [\"9677319\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Rad associates with the cytoskeleton and plasma/internal membranes in C2C12 cells through a non-lipid-dependent mechanism; it is not palmitoylated, isoprenylation inhibition does not alter its distribution, and removal of the C-terminal 11 amino acids does not affect localization. Addition of the H-Ras C-terminal 9 amino acids to truncated Rad redistributes it to the membrane skeleton independently of lipid modification.\",\n      \"method\": \"Biosynthetic [3H]palmitate labeling, lovastatin treatment, Triton X-114 phase partitioning, subcellular fractionation, C-terminal deletion and chimeric construct expression in C2C12 cells\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods defining non-lipid membrane/cytoskeletal association mechanism\",\n      \"pmids\": [\"9683526\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The GTPase-activating protein (GAP) for Rad is nm23 (NDP kinase/metastasis suppressor): nm23 antibodies deplete Rad-GAP activity from skeletal muscle cytosol, recombinant nm23 reconstitutes this activity, and GAP activity is absent with the S105N dominant-negative Rad mutant. Simultaneously, Rad (but not S105N-Rad) enhances nm23 NDP kinase activity and decreases nm23 autophosphorylation, constituting a bidirectional regulatory interaction.\",\n      \"method\": \"Rad-GAP purification, immunodepletion with nm23 antibodies, reconstitution with recombinant nm23, GTPase assays, NDP kinase assays, autophosphorylation assays, transfection of melanoma cells\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution with purified proteins plus immunodepletion, multiple orthogonal biochemical assays establishing bidirectional regulation\",\n      \"pmids\": [\"10611312\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Rad (and Gem) interact with Rho kinase (ROK) alpha and beta, functioning as negative regulators of the Rho–ROK pathway. Gem binds ROKbeta independently of RhoA in the ROKbeta coiled-coil region adjacent to the Rho binding domain, inhibiting ROKbeta-mediated phosphorylation of myosin light chain and myosin phosphatase but not LIM kinase. Rad opposes ROKalpha-mediated cell rounding. Expression of Rad or Gem in epithelial/fibroblast cells causes stress fiber and focal adhesion disassembly.\",\n      \"method\": \"Co-immunoprecipitation, ROK kinase assays, interference assays with ROK deletion mutants, overexpression in N1E-115 and epithelial/fibroblast cells with morphological readouts\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, kinase assays, deletion mutant binding domain mapping, multiple cell line functional assays\",\n      \"pmids\": [\"11956230\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Rad (and Rem) bind directly to L-type Ca2+ channel beta-subunits (CaVβ) in vivo, and co-expression of Rad or Rem with CaV1.2/CaVβ2a in HEK293 cells abolishes L-type Ca2+ channel currents. T-type (CaV3) channels that lack accessory subunits are not inhibited by Rem, indicating RGK inhibition is beta-subunit-dependent. The Rem C-terminus is critical for both CaVβ binding and channel regulation.\",\n      \"method\": \"Co-immunoprecipitation in vivo, whole-cell patch-clamp electrophysiology in HEK293 cells, C-terminal deletion analysis, overexpression in C2C12 myoblasts\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — co-IP establishing direct binding, electrophysiology confirming functional consequence, deletion analysis, multiple cell contexts\",\n      \"pmids\": [\"14623965\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"14-3-3 and calmodulin binding regulate the subcellular distribution of Rad; both Rad and Rem inhibit Ca2+ channel activity by preventing surface expression of functional Ca2+ channels. Nuclear targeting of Rad or Rem can sequester the CaVβ-subunit to the nucleus, providing a novel mechanism for Ca2+ channel downregulation. This regulation by calmodulin and 14-3-3 is Rad-specific and not observed for Rem.\",\n      \"method\": \"Subcellular fractionation, confocal immunofluorescence, co-immunoprecipitation, electrophysiology, nuclear targeting constructs in transfected cells\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (fractionation, imaging, co-IP, electrophysiology) defining novel beta-subunit nuclear sequestration mechanism\",\n      \"pmids\": [\"16298391\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Rad is a p53-regulated gene whose promoter contains a p53-binding site; p53 activation by DNA damage induces Rad expression. Rad overexpression in vascular smooth muscle cells (VSMCs) inhibits VSMC attachment and migration and reduces focal contacts and stress fibers by blocking Rho/ROK signaling. Adenoviral Rad delivery reduces neointimal formation in balloon-injured rat carotid arteries; a GDP-binding but not GTP-binding mutant of Rad increases neointimal formation.\",\n      \"method\": \"Adenoviral gene delivery in rat carotid injury model, immunohistochemistry, real-time RT-PCR, VSMC migration and adhesion assays, morphometric analysis, overexpression with signaling readouts\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo model with multiple genetic tools (WT Rad, dominant-negative mutant) and functional readouts including migration, signaling, and vascular remodeling\",\n      \"pmids\": [\"15710763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Rad is expressed in myogenic progenitor cells during skeletal muscle regeneration. Myogenic transcription factors MEF2, MyoD, and Myf-5 increase Rad promoter transcriptional activity, and this is enhanced by calcineurin (calcium-dependent phosphatase); the effect depends on a conserved NFAT binding motif in the Rad promoter.\",\n      \"method\": \"Microarray analysis, immunohistochemistry, promoter-reporter assays, calcineurin co-transfection, NFAT motif mutagenesis in regenerating mouse skeletal muscle\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter functional assays with mutagenesis and transcription factor co-expression, single lab study\",\n      \"pmids\": [\"16221735\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Overexpression of Rad in skeletal muscle in transgenic mice worsens high-fat-diet-induced insulin resistance and glucose intolerance, establishing an in vivo role for Rad as a negative regulator of muscle glucose metabolism. Rad transgenic mice also show reduced plasma triglyceride levels associated with increased lipoprotein lipase.\",\n      \"method\": \"Transgenic mice with muscle-specific (MCK promoter) Rad overexpression, glucose tolerance tests, insulin clamp, 2-deoxyglucose uptake assays, lipoprotein lipase measurements\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo transgenic model with quantitative metabolic phenotyping across multiple readouts\",\n      \"pmids\": [\"16537411\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Rad mRNA and protein are significantly decreased in human failing hearts and in pressure-overload or phenylephrine-induced cardiac hypertrophy. Gain-of-function and loss-of-function of Rad in cardiomyocytes respectively inhibits and increases phenylephrine-induced hypertrophy. Rad overexpression inhibits CaMKII activation. Rad-deficient mice show increased susceptibility to cardiac hypertrophy with elevated CaMKII phosphorylation, placing Rad upstream of CaMKII in the anti-hypertrophic pathway.\",\n      \"method\": \"Western blot of human and mouse heart tissue, adenoviral overexpression and RNAi knockdown in cardiomyocytes, Rad-knockout mice, pressure-overload model, CaMKII phosphorylation assays\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic (KO mice, KD, overexpression) and biochemical (CaMKII phosphorylation) in multiple model systems including human tissue\",\n      \"pmids\": [\"18056528\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Rad is a novel endogenous regulator of cardiac excitation-contraction (EC) coupling: adenoviral overexpression of Rad (~3-fold) in rat cardiomyocytes suppresses L-type Ca2+ channel current (ICaL), Ca2+ transients, and contractility, while ~70% Rad knockdown by RNAi increases ICaL, Ca2+ transients, and contractility. The dominant-negative mutant RadS105N mimics knockdown effects on ICaL. Rad overexpression negates beta-adrenergic receptor effects on ICaL and Ca2+ transients.\",\n      \"method\": \"Adenoviral overexpression and RNAi knockdown in rat cardiomyocytes, patch-clamp electrophysiology, Ca2+ imaging, sarcomere shortening measurement, dominant-negative mutant RadS105N\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — rigorous electrophysiology combined with gain- and loss-of-function, dominant-negative mutant, multiple functional readouts in single study\",\n      \"pmids\": [\"19926875\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Rad is a direct transcriptional target of p53: the −2934/−2905-bp region of the Rad promoter contains a p53-binding site required for p53-mediated transactivation. DNA damage induces Rad expression in a p53-dependent manner, with increased p53 occupancy and histone acetylation at the promoter. Rad expression in turn reduces inhibitory phosphorylation of cofilin at Ser3 (via ROK inhibition) and suppresses cancer cell migration and invasion. Rad knockdown promotes cell migration and abrogates p53-mediated migration suppression.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), promoter-reporter assays with deletion and mutant constructs, siRNA knockdown, wound healing and Transwell invasion assays, co-filin phosphorylation western blot\",\n      \"journal\": \"Journal of molecular medicine (Berlin, Germany)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — ChIP demonstrating direct p53 binding, promoter mutagenesis, and functional cell migration assays with KD, multiple orthogonal methods\",\n      \"pmids\": [\"21221513\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Rad inhibits cardiac fibrosis by directly binding to C/EBP-δ, thereby preventing C/EBP-δ from binding to the CTGF (connective tissue growth factor) promoter and suppressing CTGF expression. Rad-KO mice show increased cardiac fibrosis with elevated CTGF. In cardiomyocytes, Rad overexpression suppresses basal and TGF-β1-induced CTGF expression; conditioned medium from Rad-knockdown cardiomyocytes stimulates cardiac fibroblast ECM production, which is abolished by CTGF-neutralizing antibody.\",\n      \"method\": \"Rad-KO mice (Sirius Red staining), Western blot, adenoviral overexpression and RNAi knockdown, chromatin immunoprecipitation, co-immunoprecipitation, conditioned medium/neutralizing antibody experiments\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct binding shown by co-IP, functional consequences in KO mice and cell-based systems with multiple orthogonal methods\",\n      \"pmids\": [\"21382976\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Genetic deletion of Rad in mice (Rad−/−) increases maximum L-type Ca2+ channel current (ICaL) with faster decay kinetics and lower activation voltage, elevates diastolic and twitch Ca2+ transients, and enhances sarcomere shortening, phenocopying β-adrenergic receptor stimulation without inducing cardiac hypertrophy. In isolated working hearts, +dP/dt was elevated at baseline with blunted response to further β-AR stimulation.\",\n      \"method\": \"Rad−/− mouse cardiomyocytes, patch-clamp electrophysiology, Fura-2 Ca2+ imaging, sarcomere shortening, isolated working heart preparations, echocardiography\",\n      \"journal\": \"Journal of the American Heart Association\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO model with rigorous electrophysiology, Ca2+ imaging, and contractility measurements in multiple preparations\",\n      \"pmids\": [\"24334906\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"RRAD is a p53 transcriptional target that represses hypoxia-stimulated glycolysis in cancer cells. Ectopic RRAD expression reduces glycolysis and GLUT1 translocation to the plasma membrane; RRAD knockdown promotes glycolysis. Under hypoxia, p53 induces RRAD which in turn inhibits GLUT1 membrane translocation. siRNA knockdown of RRAD abolishes p53's ability to repress hypoxia-induced glycolysis.\",\n      \"method\": \"Ectopic expression and siRNA knockdown in lung cancer cells, glucose uptake assays, lactate production assays, GLUT1 subcellular fractionation and immunofluorescence, hypoxic conditions\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal gain- and loss-of-function experiments with functional metabolic readouts and GLUT1 localization assays\",\n      \"pmids\": [\"25114038\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"RRAD promotes EGFR-mediated STAT3 activation in glioblastoma by physically associating with EGFR and EEA1 (early endosome antigen 1), enhancing EGFR stability and endosome-associated nuclear translocation of EGFR, thereby activating STAT3 and stem cell factors.\",\n      \"method\": \"Co-immunoprecipitation (RRAD–EGFR, RRAD–EEA1), RRAD knockdown and overexpression in GBM cells, STAT3 phosphorylation assays, sphere formation assays, in vivo tumorigenesis\",\n      \"journal\": \"Molecular cancer therapeutics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP for binding, functional readouts with KD/OE, single lab study\",\n      \"pmids\": [\"25313011\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"RRAD negatively regulates the Warburg effect in lung cancer cells by directly binding the p65 subunit of NF-κB and inhibiting nuclear translocation of p65, thereby reducing NF-κB-dependent GLUT1 membrane translocation and aerobic glycolysis. Blocking NF-κB signaling abolishes RRAD's inhibitory effects on GLUT1 translocation.\",\n      \"method\": \"Co-immunoprecipitation (RRAD–p65), nuclear fractionation assays for p65 translocation, NF-κB reporter assays, siRNA knockdown and overexpression in lung cancer cells, glucose uptake and lactate assays\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct binding demonstrated by co-IP, functional cascade confirmed with NF-κB inhibitors and p65 fractionation, multiple orthogonal methods\",\n      \"pmids\": [\"25893381\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"A rare RRAD missense variant (p.R211H), identified in a familial Brugada syndrome pedigree, causes reduced action potential upstroke velocity, prolonged action potentials, increased early afterdepolarizations, decreased Na+ peak current, increased Na+ persistent current, decreased L-type Ca2+ current, and abnormal actin distribution with fewer focal adhesions in iPSC-derived cardiomyocytes compared to intra-familial controls. Genome editing to introduce p.R211H into control iPSCs confirmed these defects.\",\n      \"method\": \"Whole-exome sequencing, iPSC-CMs from affected patients, patch-clamp electrophysiology, CRISPR genome editing, actin immunofluorescence, focal adhesion assays\",\n      \"journal\": \"European heart journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — CRISPR-confirmed variant with rigorous electrophysiology and structural readouts in human iPSC-CMs\",\n      \"pmids\": [\"31114854\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Myocardial-restricted inducible RAD knockout (RADΔ/Δ) mice show increased ICaL with β-AR-modulated phenotype at baseline, enhanced cytosolic Ca2+ handling, increased contractile function, elevated SERCA2a expression, and faster lusitropy, without structural cardiac remodeling or hypertrophy. This demonstrates that cardiac RAD ablation specifically enhances Ca2+ dynamics beneficially.\",\n      \"method\": \"Conditional inducible cardiac-specific Cre-lox KO, patch-clamp electrophysiology, Fura-2 Ca2+ transients, echocardiography, radiotelemetry, sarcomere shortening, Western blot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cardiac-specific KO distinguishing cardiac from systemic RAD effects, multiple orthogonal methods\",\n      \"pmids\": [\"31147441\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"RRAD binds actin gamma 1 (ACTG1) and suppresses aerobic glycolysis in hepatocellular carcinoma through downregulation of ACTG1 expression; ACTG1 promotes HCC proliferation by regulating the cell cycle and inhibiting apoptosis via the mitochondrial pathway.\",\n      \"method\": \"Co-immunoprecipitation (RRAD–ACTG1), overexpression and knockdown in SK-Hep-1 and Huh7 cells, glycolysis/lactate assays, cell cycle analysis, apoptosis assays, in vivo xenograft\",\n      \"journal\": \"OncoTargets and therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP for binding partner, functional assays with gain/loss-of-function, single lab study\",\n      \"pmids\": [\"30881024\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Adrenergic CaV1.2 channel activation via Rad requires an intact rigid IS6-α-interaction domain helix in the α1C I-II loop and CaVβ binding to α1C. Introduction of polyglycine flexibility in the I-II loop eliminates β-adrenergic stimulation of CaV1.2 current despite intact CaVβ binding, placing the I-II loop structural rigidity as mechanistically essential for both Rad-mediated inhibition relief and β-AR regulation.\",\n      \"method\": \"Transgenic mice expressing α1C I-II loop mutants (GGG-α1C, exon9* variant, AID-binding mutants), patch-clamp electrophysiology in cardiomyocytes and heterologous systems, β-AR stimulation\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — transgenic mouse models with defined structural mutations and rigorous electrophysiology, multiple constructs in one study\",\n      \"pmids\": [\"33086983\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Rad is essential for PKA regulation of CaV1.2: reconstitution of the complete β-adrenergic receptor → PKA → CaV1.2 cascade in Xenopus oocytes demonstrates that ~80% of PKA-mediated CaV1.2 upregulation is Rad-dependent (requiring PKA phosphorylation of Rad) while ~20% is Rad-independent. β1-AR and β2-AR differ in the features of their CaV1.2 regulation in this system.\",\n      \"method\": \"Heterologous reconstitution in Xenopus oocytes with β1-AR or β2-AR, PKA, CaV1.2 subunits, and Rad; two-electrode voltage clamp electrophysiology; systematic pharmacological and genetic dissection\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — complete pathway reconstitution in defined heterologous system with rigorous dissection of Rad-dependent vs independent components\",\n      \"pmids\": [\"34001616\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Four PKA-phosphorylated residues in Rad are the primary mechanism underlying β-adrenergic augmentation of calcium influx in cardiomyocytes. Rad phosphosite-mutant (4SA-Rad) knock-in mice show reduced basal ICaL, near-complete attenuation of β-AR contractile response, reduced heart rate, and diminished exercise capacity. Expression of CaVβ-subunit mutants unable to bind 4SA-Rad restores basal Ca2+ influx and contractility to adrenergically augmented wild-type levels, rescuing the 4SA-Rad failing heart phenotype.\",\n      \"method\": \"4SA-Rad phosphosite knock-in mice, transgenic mice expressing Rad-binding-deficient CaVβ subunits, patch-clamp electrophysiology, echocardiography, exercise testing, cardiac function assays\",\n      \"journal\": \"Nature cardiovascular research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — phosphosite knock-in mice combined with CaVβ rescue transgenic mice, rigorous electrophysiology and in vivo phenotyping, multiple orthogonal genetic strategies\",\n      \"pmids\": [\"36424916\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"RRAD expression is upregulated in senescent cells across multiple senescence induction modes and acts as a negative regulator of cellular senescence by reducing reactive oxygen species levels. Both p53 and NF-κB bind to RRAD genomic regions and modulate RRAD transcription (co-activation by both factors).\",\n      \"method\": \"Pan-senescence transcriptome meta-analysis, validation in human fibroblasts (Ras-, H2O2-, ionizing radiation-, hydroxyurea-, etoposide-, replicative-induced senescence), ROS measurements, ChIP for p53 and NF-κB binding to RRAD locus\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — validated across six senescence modes with ChIP, but functional mechanism (ROS reduction) demonstrated in single lab study\",\n      \"pmids\": [\"30391675\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Rad promotes growth and tumorigenicity in breast cancer: stable transfection of Rad into Rad-negative MDA-MB435 breast cancer cells increases colony formation in soft agar and tumor growth rate in nude mice. Co-expression of nm23 inhibits these effects. Growth-promoting effects map to the N- and C-terminal regions of Rad rather than its GTPase domain.\",\n      \"method\": \"Stable transfection into breast cancer cell lines, soft agar colony formation, nude mouse xenograft, co-transfection with nm23, deletion/mutation analysis of Rad domains\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro and in vivo functional assays with domain mapping, single lab study\",\n      \"pmids\": [\"11280768\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RRAD (RAD GTPase) is a small Ras-related GTPase that functions as an endogenous negative regulator of L-type voltage-gated Ca2+ channels (CaV1.2) by directly binding CaVβ subunits; PKA-mediated phosphorylation of four Rad residues is the primary mechanism by which β-adrenergic stimulation relieves Rad-dependent channel inhibition to augment cardiac contractility. Beyond Ca2+ channel regulation, Rad inhibits the Rho–Rho kinase pathway (via direct binding to ROK), is a direct transcriptional target of p53 and suppresses cell migration through cofilin/actin dynamics, represses aerobic glycolysis (Warburg effect) by binding p65-NF-κB to block GLUT1 membrane translocation, inhibits cardiac hypertrophy through the CaMKII pathway, and prevents cardiac fibrosis by binding C/EBP-δ to suppress CTGF expression; its GTPase activity is regulated by nm23 as a GAP, and phosphorylation by CaMKII, PKA, PKC, and CKII modulates its interaction with calmodulin and GTP binding.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"RRAD (Rad) is a muscle-enriched, ~29 kDa Ras-related small GTPase that binds and hydrolyzes GTP and acts principally as an endogenous brake on L-type voltage-gated Ca2+ channels in the heart [#0, #1, #9]. It inhibits CaV1.2 by binding directly to the channel's CaV\\u03b2 accessory subunit, a requirement demonstrated by the selective inhibition of \\u03b2-subunit-bearing channels and by nuclear sequestration of CaV\\u03b2 when Rad is targeted to the nucleus [#9, #10]. Loss of Rad in cardiomyocytes raises ICaL, Ca2+ transients, SERCA2a, and contractility, phenocopying \\u03b2-adrenergic stimulation without hypertrophy, identifying Rad as the central regulator of cardiac excitation\\u2013contraction coupling [#15, #18, #23]. \\u03b2-adrenergic/PKA signaling relieves this inhibition: PKA phosphorylation of four Rad residues accounts for the bulk of PKA-mediated CaV1.2 upregulation, and channel activation additionally requires structural rigidity of the \\u03b11C I-II loop and CaV\\u03b2 binding [#25, #26, #27]. A familial RRAD missense variant (p.R211H) causes Brugada-syndrome electrophysiological defects in iPSC-derived cardiomyocytes, linking the gene to inherited arrhythmia [#22]. Rad activity is shaped by partner and post-translational inputs: nm23/NDP kinase serves as its GAP in a bidirectional interaction, calcium-dependent calmodulin and 14-3-3 binding govern its localization, and CaMKII, PKA, PKC, and CKII phosphorylate C-terminal serines to modulate CaM binding and GTP binding [#4, #5, #7, #10]. Beyond Ca2+ handling, Rad antagonizes the Rho/ROK pathway to drive stress-fiber and focal-adhesion disassembly and suppress cell migration, and it limits cardiac hypertrophy via CaMKII and cardiac fibrosis by binding C/EBP-\\u03b4 to repress CTGF [#8, #11, #14, #17]. As a direct p53 transcriptional target, Rad restrains glycolysis by blocking GLUT1 membrane translocation (in part through binding NF-\\u03baB p65) and suppresses migration via cofilin/actin dynamics [#16, #19, #21]. In skeletal muscle and adipocytes, Rad overexpression inhibits insulin-stimulated glucose uptake and worsens diet-induced insulin resistance in vivo [#3, #13].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Established RRAD as a previously unknown small GTPase and tied its discovery to a disease context (overexpression in type II diabetic skeletal muscle), defining the gene to be studied.\",\n      \"evidence\": \"Subtraction cloning of human skeletal muscle cDNA and protein characterization\",\n      \"pmids\": [\"8248782\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No biochemical activity demonstrated\", \"Causal role in diabetes not yet tested\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Confirmed Rad is a functional GTP-binding protein with regulatable GTPase activity and a PKA-phosphorylated C-terminus, providing the biochemical scaffold for all downstream regulation.\",\n      \"evidence\": \"GST-fusion GTP/GDP binding and GTPase assays, mutagenesis, and in vitro PKA phosphorylation\",\n      \"pmids\": [\"7876254\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"GAP identity unknown\", \"Cellular consequences of GTP loading unknown\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"First linked Rad to the cytoskeleton and to glucose metabolism, showing nucleotide-dependent tropomyosin binding and inhibition of intrinsic glucose transporter activity.\",\n      \"evidence\": \"Co-IP, far-Western, fractionation, and glucose-uptake assays in muscle/fat cell lines\",\n      \"pmids\": [\"8557685\", \"8798502\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of transporter inhibition not resolved\", \"In vivo relevance untested at this stage\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Defined a calcium-sensing module: calcium-dependent calmodulin binding at the C-terminus and CaMKII as a kinase/partner, connecting Rad to Ca2+/calmodulin signaling.\",\n      \"evidence\": \"CaM-Sepharose pulldown, mutagenesis mapping, co-IP, and in vitro CaMKII assay\",\n      \"pmids\": [\"9115241\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional output of CaM binding not yet shown\", \"Link to channel regulation not yet made\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Mapped a multi-kinase phosphorylation code (CaMKII, PKA, PKC, CKII) controlling CaM interaction and GTP binding, establishing how signaling inputs tune Rad.\",\n      \"evidence\": \"In vitro kinase assays, phosphopeptide mapping, mutagenesis, GTP-binding and CaM pulldown assays\",\n      \"pmids\": [\"9677319\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which phosphosites operate in vivo not defined here\", \"Downstream effectors still unknown\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Resolved how Rad associates with membranes/cytoskeleton, showing a non-lipid (non-prenylation, non-palmitoylation) mechanism distinct from canonical Ras targeting.\",\n      \"evidence\": \"Palmitate labeling, lovastatin treatment, Triton X-114 partitioning, deletion/chimera constructs in C2C12\",\n      \"pmids\": [\"9683526\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise targeting motif not pinpointed\", \"Role of localization in function not yet tied to a substrate\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Identified nm23/NDP kinase as the long-sought Rad GAP and revealed a reciprocal, bidirectional regulatory interaction controlling Rad's nucleotide state.\",\n      \"evidence\": \"GAP purification, immunodepletion, recombinant reconstitution, GTPase/NDP-kinase/autophosphorylation assays\",\n      \"pmids\": [\"10611312\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological setting of the Rad\\u2013nm23 cycle unclear\", \"GEF for Rad not identified\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Placed Rad as a negative regulator of the Rho/ROK pathway, explaining its effects on actomyosin, stress fibers, and focal adhesions.\",\n      \"evidence\": \"Reciprocal co-IP, ROK kinase assays, deletion mapping, morphological assays in multiple cell lines\",\n      \"pmids\": [\"11956230\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ROK binding is nucleotide-state dependent not fully defined\", \"In vivo cardiovascular relevance not yet shown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Discovered Rad's defining activity\\u2014direct CaV\\u03b2 binding and CaV\\u03b2-dependent abolition of L-type Ca2+ currents\\u2014establishing the RGK-channel inhibition paradigm.\",\n      \"evidence\": \"In vivo co-IP and whole-cell patch-clamp with CaV1.2/CaV\\u03b2 in HEK293, plus deletion analysis\",\n      \"pmids\": [\"14623965\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of current loss (trafficking vs gating) not resolved here\", \"Endogenous cardiac relevance untested\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Connected localization control (calmodulin/14-3-3) to channel regulation, showing Rad downregulates channels by preventing CaV\\u03b2 surface expression including via nuclear sequestration.\",\n      \"evidence\": \"Fractionation, confocal imaging, co-IP, electrophysiology, nuclear-targeting constructs\",\n      \"pmids\": [\"16298391\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of nuclear sequestration vs other mechanisms in vivo unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Established Rad as a p53-induced, vasoprotective regulator that limits VSMC migration and neointima formation via Rho/ROK inhibition, with nucleotide-state dependence.\",\n      \"evidence\": \"Adenoviral delivery in rat carotid injury, RT-PCR, migration/adhesion assays, GDP/GTP mutants\",\n      \"pmids\": [\"15710763\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct p53 binding to promoter not yet shown here\", \"Human disease relevance untested\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Linked Rad transcription to myogenic and calcium-dependent programs, identifying MEF2/MyoD/Myf-5 and calcineurin/NFAT control of the Rad promoter.\",\n      \"evidence\": \"Microarray, promoter-reporter assays, calcineurin co-transfection, NFAT-motif mutagenesis in regenerating muscle\",\n      \"pmids\": [\"16221735\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab promoter study\", \"Functional role of Rad in regeneration not directly tested\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Provided in vivo proof that Rad negatively regulates muscle glucose metabolism, with muscle-specific overexpression worsening insulin resistance.\",\n      \"evidence\": \"MCK-Rad transgenic mice, glucose tolerance/insulin clamp, 2-DG uptake, lipoprotein lipase assays\",\n      \"pmids\": [\"16537411\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular target mediating transporter inhibition unresolved\", \"Loss-of-function metabolic phenotype not addressed\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Defined an anti-hypertrophic role with Rad upstream of CaMKII, linking reduced cardiac Rad to human heart failure and hypertrophy.\",\n      \"evidence\": \"Human/mouse heart Western blots, adenoviral OE/RNAi, Rad-KO mice, pressure overload, CaMKII phosphorylation\",\n      \"pmids\": [\"18056528\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Rad restrains CaMKII activation mechanistically unclear\", \"Interplay with Ca2+ channel regulation not dissected\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Demonstrated Rad as an endogenous bidirectional regulator of cardiac EC coupling and \\u03b2-AR responsiveness via ICaL, moving the channel paradigm into native cardiomyocytes.\",\n      \"evidence\": \"Adenoviral OE and RNAi in rat cardiomyocytes, patch-clamp, Ca2+ imaging, sarcomere shortening, RadS105N\",\n      \"pmids\": [\"19926875\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular link between Rad and \\u03b2-AR signaling not yet defined\", \"Phosphorylation control of relief untested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Established direct p53 binding to the Rad promoter and a p53\\u2192Rad\\u2192ROK/cofilin axis suppressing cancer cell migration and invasion.\",\n      \"evidence\": \"ChIP, promoter deletion/mutant reporters, siRNA, wound-healing/invasion assays, cofilin phosphorylation blots\",\n      \"pmids\": [\"21221513\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo metastasis suppression not tested\", \"Relative role of cofilin vs other ROK targets unclear\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identified an anti-fibrotic mechanism in which Rad binds C/EBP-\\u03b4 to block CTGF transcription, with Rad-KO mice showing increased cardiac fibrosis.\",\n      \"evidence\": \"Rad-KO mice, ChIP, co-IP, adenoviral OE/RNAi, conditioned-medium/CTGF-neutralization experiments\",\n      \"pmids\": [\"21382976\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether C/EBP-\\u03b4 binding depends on Rad nucleotide state unknown\", \"Crosstalk with hypertrophy/EC-coupling roles unexplored\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Showed that germline Rad deletion enhances ICaL, Ca2+ transients, and contractility, phenocopying \\u03b2-AR stimulation without hypertrophy\\u2014cementing Rad as the cardiac channel brake.\",\n      \"evidence\": \"Rad\\u2212/\\u2212 cardiomyocytes, patch-clamp, Fura-2 imaging, sarcomere shortening, working-heart preparations, echocardiography\",\n      \"pmids\": [\"24334906\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Systemic vs cardiac-intrinsic contribution not separated here\", \"Mechanism of \\u03b2-AR mimicry not molecularly defined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established Rad as a p53 effector that represses hypoxic glycolysis by blocking GLUT1 membrane translocation, linking the gene to the Warburg effect.\",\n      \"evidence\": \"Ectopic expression/siRNA in lung cancer cells, glucose/lactate assays, GLUT1 fractionation and imaging under hypoxia\",\n      \"pmids\": [\"25114038\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular target controlling GLUT1 not yet identified here\", \"In vivo tumor metabolism untested\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Described a context-dependent pro-tumor role in glioblastoma, where RRAD associates with EGFR and EEA1 to enhance EGFR stability and STAT3 activation.\",\n      \"evidence\": \"Co-IP (RRAD\\u2013EGFR, RRAD\\u2013EEA1), KD/OE in GBM cells, STAT3 assays, sphere formation, in vivo tumorigenesis\",\n      \"pmids\": [\"25313011\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab study\", \"Reconciliation with tumor-suppressive roles elsewhere unresolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Provided a molecular handle for glycolysis repression: RRAD binds NF-\\u03baB p65 to block its nuclear translocation and thereby GLUT1 surface expression.\",\n      \"evidence\": \"Co-IP (RRAD\\u2013p65), p65 fractionation, NF-\\u03baB reporter assays, siRNA/OE, glucose/lactate assays in lung cancer cells\",\n      \"pmids\": [\"25893381\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether p65 binding is direct and nucleotide-dependent unclear\", \"Integration with p53 induction not dissected\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Linked RRAD to cellular senescence as a ROS-lowering negative regulator co-activated by p53 and NF-\\u03baB across multiple senescence modes.\",\n      \"evidence\": \"Pan-senescence meta-analysis, validation in fibroblasts, ROS measurement, ChIP for p53 and NF-\\u03baB at the RRAD locus\",\n      \"pmids\": [\"30391675\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of ROS reduction shown in single lab\", \"Connection to GTPase activity untested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Linked RRAD to inherited arrhythmia by showing a familial p.R211H variant reproduces Brugada-syndrome electrophysiology and cytoskeletal defects in iPSC-cardiomyocytes.\",\n      \"evidence\": \"WES, patient and CRISPR-edited iPSC-CMs, patch-clamp, actin/focal-adhesion imaging\",\n      \"pmids\": [\"31114854\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanistic basis of Na+ current changes incompletely defined\", \"Genotype frequency/penetrance not established\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Used cardiac-specific inducible KO to prove that heart-intrinsic Rad ablation beneficially enhances Ca2+ dynamics and contractility without remodeling, separating cardiac from systemic effects.\",\n      \"evidence\": \"Conditional cardiac Cre-lox KO, patch-clamp, Fura-2 transients, echocardiography, telemetry, Western blot\",\n      \"pmids\": [\"31147441\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Long-term consequences and therapeutic window not addressed\", \"Molecular relief mechanism still pending phosphosite proof\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Added a metabolic effector in hepatocellular carcinoma, with RRAD binding ACTG1 and suppressing glycolysis through ACTG1 downregulation.\",\n      \"evidence\": \"Co-IP (RRAD\\u2013ACTG1), OE/KD in HCC lines, glycolysis assays, cell cycle/apoptosis assays, xenografts\",\n      \"pmids\": [\"30881024\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab study\", \"How RRAD downregulates ACTG1 mechanistically unclear\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Defined the structural requirement on the channel side, showing the \\u03b11C I-II loop rigidity and CaV\\u03b2 binding are essential for Rad-mediated inhibition relief and \\u03b2-AR regulation.\",\n      \"evidence\": \"Transgenic mice with \\u03b11C I-II loop mutants, patch-clamp in cardiomyocytes and heterologous systems, \\u03b2-AR stimulation\",\n      \"pmids\": [\"33086983\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-level structure of the Rad\\u2013CaV\\u03b2\\u2013\\u03b11C complex not resolved\", \"Conformational changes upon phosphorylation not visualized\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Demonstrated by full pathway reconstitution that Rad is the dominant (~80%) mediator of PKA-driven CaV1.2 upregulation, requiring PKA phosphorylation of Rad.\",\n      \"evidence\": \"Xenopus oocyte reconstitution of \\u03b2-AR\\u2192PKA\\u2192CaV1.2 with two-electrode voltage clamp and genetic dissection\",\n      \"pmids\": [\"34001616\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the residual Rad-independent component unresolved\", \"In vivo confirmation of phosphosite necessity pending\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Provided definitive in vivo proof that four PKA phosphosites in Rad mediate \\u03b2-adrenergic augmentation of cardiac Ca2+ influx, with CaV\\u03b2-binding-deficient mutants rescuing the phosphosite-mutant heart.\",\n      \"evidence\": \"4SA-Rad knock-in mice plus Rad-binding-deficient CaV\\u03b2 transgenics, patch-clamp, echocardiography, exercise testing\",\n      \"pmids\": [\"36424916\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Spatial/structural mechanism of phosphorylation-induced unbinding not visualized\", \"Therapeutic targeting of this node untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How Rad's GTPase cycle, calmodulin/14-3-3-controlled localization, and PKA phosphorylation are integrated structurally to release CaV\\u03b2, and how the gene's many cancer/metabolic roles are reconciled with its cardiac function, remain open.\",\n      \"evidence\": \"No single study in the timeline unifies the structural, biochemical, and physiological mechanisms\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No atomic structure of the Rad\\u2013CaV\\u03b2 complex in the corpus\", \"GEF for Rad unidentified\", \"Context-dependent pro- vs anti-tumor roles unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003924\", \"supporting_discovery_ids\": [1, 7]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [9, 15, 26, 27]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [17, 21]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [2, 6]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [6, 9, 10]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [10]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-397014\", \"supporting_discovery_ids\": [15, 18, 23, 27]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [8, 26, 27]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [3, 13, 19, 21]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [16, 28]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"CACNB2\", \"CALM1\", \"NME1\", \"ROCK1\", \"ROCK2\", \"RELA\", \"CEBPD\", \"EGFR\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}